Next Article in Journal
Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-ERK Signaling Pathway in Endometrial Cancer Cells
Previous Article in Journal
Volatile Compound Markers in Beef Irradiated with Accelerated Electrons
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Research Progress in Traditional Applications, Phytochemistry, Pharmacology, and Safety Evaluation of Cynomorium songaricum

by
Jin Zhang
1,2,
Xingyi Chen
1,2,
Lu Han
1,2,
Biao Ma
1,2,
Mengting Tian
1,2,
Changcai Bai
1,2,* and
Ye Zhang
3,*
1
College of Pharmacy, Ningxia Medical University, Yinchuan 750004, China
2
Key Laboratory of Ningxia Ethnomedicine Modernization, Ministry of Education, Ningxia Medical University, Yinchuan 750004, China
3
College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, China
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(5), 941; https://doi.org/10.3390/molecules29050941
Submission received: 16 January 2024 / Revised: 12 February 2024 / Accepted: 13 February 2024 / Published: 21 February 2024

Abstract

:
Cynomorium songaricum Rupr. (CSR) belongs to the family Cynomoriaceae. It is a perennial succulent parasitic herb with a reddish-brown coloration, predominantly submerged in sand and lacking chlorophyll. Traditionally, it has been used in ethnic medicine to treat various diseases, such as gastric ulcers, indigestion, bowel movements, and improving sexual function. To comprehensively collect CSR data, extensive literature searches were conducted using medical, ecological, and scientific databases such as Google Scholar, PubMed, Science Direct, Web of Science, and China National Knowledge Infrastructure (CNKI). This article summarizes and categorizes research on the uses, phytochemical characteristics, pharmacological activities, and toxicity of ethnic medicine, with the aim of establishing a solid foundation and proposing new avenues for exploring and developing potential applications of CSR. So far, a total of 98 compounds have been isolated and identified from CSR, including flavonoids, terpenes, steroids, and other compounds. It is worth noting that flavonoids and polysaccharides have significant antioxidant and anti-inflammatory properties. In addition, these compounds also show good application prospects in anti-tumor, antioxidant, anti-aging, anti-fatigue, anti-diabetes, and other aspects. Although extensive progress has been made in the basic research of CSR, further research is still needed to enhance the understanding of its mechanism of action and explore more unknown compounds. Our review indicates that CSR has broad prospects and deserves further research.

1. Introduction

Cynomorium is a genus containing two species, C. songaricum Rupr. and C. coccineum L., and is in the family Cynomoriaceae. These two types are mainly distributed in dry, rocky, or sandy soil areas, mainly appearing in the Northern Hemisphere. For centuries, folk medicine has been widely applied in countries such as Europe, North Africa, East Asia, and West Asia. Cynomorium songaricum Rupr. (CSR), a dried succulent stem of a rare endangered medicinal herb that belongs to the genus of Cynomorium L. [1], is mainly distributed in Xinjiang, Qinghai, Gansu, Ningxia, Inner Mongolia, Shaanxi and other northwestern regions in China [2]. At present, CSR has been classified as vulnerable (VU) by the International Union for Conservation of Nature (IUCN), and as a Grade II protected plant by the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) [3].
As a plant with homologous medicinal and edible properties, CSR is widely used both domestically and internationally. There are some common ways to consume CSR in North Africa, Europe, East Asia, and West Asia due to its nutritional and health value. For example, fresh CSR can be used for steaming rice, pancakes, etc., while dry CSR can be used for boiling soup, brewing wine, making health foods, etc. [4].
The medicinal history of CSR can be traced back to the Yuan Dynasty, as recorded in the Ben Cao Yan Yi Bu Yi (Yuan Dynasty, A.D. 1347) which has the effects of tonifying kidney yang, benefiting essence and blood, and moistening the intestines and relieving constipation [5]. The dried fleshy stem of CSR can tonify kidney Qi, enhance essence blood nourishment, and treat problems such as weakness and impotence [6]. CSR whole grass can treat impotence caused by kidney deficiency, multiple dreams, spermatogenesis, waist and knee weakness, and other symptoms. However, it can also be used in the treatment of diarrhea, women’s leucorrhea, gum bleeding, and other diseases [7].
CSR is rich in polyphenols and polysaccharides, both with biological activities such as scavenging free radicals in the body. As a result, CSR is also known as “the elixir of youth” because it prevents lipid oxidation, aging, cardiovascular disease, cancer, and radiation damage [8]. In recent years, the chemical composition of CSR has been gradually revealed, and it has been reported that it contains flavonoids [9], triterpenoids [10], sugars and glycosides [11], steroids [12], organic acids [13] and other components. Modern pharmacological studies have shown that the extract has the ability to promote cell regeneration and metabolism; enhance immune regulatory function [14]; has anti-cancer [15], anti-viral [16], and anti-aging properties [17]; and relieves fatigue [18].
The present paper provides a comprehensive review of the botanical characteristics, traditional medicinal history, phytochemical composition, pharmacological research, and toxicological research progress of CSR. This systematic analysis aims to offer valuable insights into its clinical application and further research and development in the field of functional foods.

2. Materials and Methods

Google Scholar (http://scholar.google.com/, accessed on 27 May 2023), PubMed (http://www.ncbi.nlm.nih.gov/pubmed/, accessed on 27 May 2023), Science Direct (http://www.sciencedirect.com/, accessed on 27 May 2023), Web of Science (http://apps.webofknowledge.com/, accessed on 27 May 2023) and China National Knowledge Infrastructure (https://www.cnki.net/, accessed on 27 May 2023) and other medical, ecological, and scientific databases were used to conduct an extensive literature search to classify the distribution of CSR and preliminary studies. Various keyword combinations such as “Cynomorium songaricum Rupr.” and “traditional use”, “phytochemistry”, “pharmacology” and “isolated compounds” were used to collect scientific evidence on plant description, traditional use, phytochemical composition, and pharmacological properties of CSR. EndNote (https://endnote.com/, accessed on 27 May 2023) was used to collate the published literature. And we used the PubChem chemical database (https://pubchem.ncbi.nlm.nih.gov/search/search.cgi/, accessed on 27 May 2023), and other open access and redraw the chemical structure of CSR compounds. The structure of CSR compounds was plotted in Chem Draw 18.0 software.

3. Botany

3.1. Characteristics of Plants

CSR is a perennial succulent parasitic herb with a reddish-brown coloration, predominantly submerged in sand and lacking chlorophyll (Figure 1). CSR possesses a few triangular scales in its middle and upper sections. Its inflorescence is terminal and clavate, adorned with scaly leaves, featuring bisexual flowers consisting of petals, stamens, and an ovary. Male flowers typically have four perianth pieces, while the pistil undergoes degradation. Female flowers exhibit a lower ovary with usually 5–6 perianth pieces enclosing one pendulous ovule at the apex, male flowers degenerate accordingly. The fruit resembles a nut [19].

3.2. Growth Environment and Regional Distribution

CSR is a rare and endangered medicinal plant mainly distributed in northwest China, such as Inner Mongolia (Red), Gansu (Blue), Xinjiang (Orange), Qinghai (Purple), and Ningxia (Yellow) (Figure 2). Growing in temperate and subtropical regions, it can grow in areas with lower elevations or up to 2000 m above sea level. It likes warm and humid climates, has strong adaptability, and can grow in areas with full or partial sunlight. The minimum temperature is generally required to be no lower than −10 °C. It can withstand high temperatures even in hotter summers. It can adapt to different types of soil but it is best to avoid excessively humid or poor soil. Wild CSR is the main source, with a domestic accumulation of about 30,000 tons. Under normal circumstances, about 1500 tons are harvested annually. However, the existing wild CSR resources are only concentrated in the Hedong sandy land of Pingluo County and their distribution area has been decreasing year by year [20]. There are five host plants, namely Nitraria sphaerocarpa, Nitraria sibirica, Nitraria tangutorum, Zygophyllum xanthoxylon, and Peganum multisectum [21]. The lifecycle of CSR mainly includes several stages: seed germination, parasitic localization, parasitic attachment, growth cycle, and seed dispersal (Figure 3). Under natural conditions, CSR vegetative growth does not necessitate external light, and the entire growth process takes 4–5 years. However, through artificial cultivation, CSR can be harvested within 3–4 years [22]. CSR seeds germinate under favorable conditions, producing a specialized “bud tube organ”. The terminal regions of this structure expand and adhere to the host plant’s root system, invading it. Once connected to the host plant’s vascular bundle, a parasitic relationship is established, leading to new gemmules [23].

4. Traditional Uses

The use of CSR in Asia has a long history, primarily for erectile dysfunction, premature ejaculation, and spermatogenesis enhancement. It was first recorded in Ben Cao Yan Yi Bu Yi (Yuan Dynasty, A.D. 1347). Later, the use of the plant was documented in other well-known medicinal works, including Ben Cao Meng Quan (Ming Dynasty, A.D. 1565), Ben Cao Gang Mu (Ming Dynasty, A.D. 1590), Ben Cao Qie Yao (Ming Dynasty, A.D. 1609), Ben Cao Bei Yao (Qing Dynasty, A.D. 1694). The traditional preparation of CSR primarily involves the formulation of pills, with notable examples being Huqian wan and Suoyang gujing wan. Its primary function lies in nourishing the kidneys and invigorating Yang, albeit with distinct effects (Table 1).
CSR is primarily utilized in clinical practice for the treatment of andrological and gynecological disorders. Its key therapeutic advantages include enhancing sexual function, regulating endocrine function, and promoting gastrointestinal health. Besides its significant medicinal value, it also finds application in culinary preparations such as steamed rice or pancakes when fresh. It is also incorporated into soups, wines, or health foods when dried. Prolonged consumption can improve immunity and prevent diabetes [24]. Additionally, CSR can serve as a supplementary source of essential trace elements for the human body. CSR exhibits robust vitality and adaptability, thriving in arid deserts, rocky crevices, and harsh environments characterized by drought and wind erosion. It possesses significant ecological value in terms of enhancing environmental conditions, preserving soil stability, and maintaining ecological equilibrium [25].
Table 1. The traditional uses of Cynomorium songaricum Rupr. in China.
Table 1. The traditional uses of Cynomorium songaricum Rupr. in China.
Prescription NameMain ComponentsTraditional UsesAncient BooksReferences
Huqian wanCynomorium, Cupressus funebris, Anemarrhena asphodeloides, orange peel, Paeonia lactiflora, tortoise plastron, etc.Curing impotenceDan Xi Xin Fa (Ming Dynasty, A.D. 1481)[26]
Guilu bushen wanCynomorium, Epimedium brevicornu, common jujube seed, Ipomoea batatas, Rubus idaeus, orange peel, etc.Curing impotenceChinese Pharmacopoeia 2020[27]
Suoyang gujing wanCynomorium, Cuscuta chinensis, Alisma plantago-aquatica, Achyranthes bidentata, Anemarrhena asphodeloides, Poria cocos, etc.Curing spermatorrheaChinese Pharmacopoeia 2020[28]
Guben wanCynomorium, Panax ginseng, Oxytropis xinglongshanica, Sinocrassula indica, clam powder, Atractylodes macrocephala, etc.Curing chronic renal failureSong Ya Zun Sheng (Qing Dynasty, A.D. 1695)[29]
Dabuyin wanCynomorium, Cupressus funebris, Anemarrhena asphodeloides, Paeonia lactiflora, orange peel, Stephania tetrandra, etc.Curing diabetic nephropathyTong Shou Lu (Qing Dynasty, A.D. 1762)[30]
Xusi danCynomorium, Fossilizid, Concha ostreae, Eucommia ulmoides, orange peel, Atractylodes macrocephala, etc.Curing male infertilityFu Ke Yu Chi (Qing Dynasty, A.D. 1644–1911)[31]
Jiawei huqian wanCynomorium, Ipomoea batatas, Schisandra chinensis, Achyranthes bidentata, Cupressus funebris, Angelica sinensis, etc.Strong bones and musclesYi Xue Liu Yao (Ming Dynasty, A.D. 1609)[32]
Shenlu jianbu wanCynomorium, Cupressus funebris, Anemarrhena asphodeloides, orange peel, Zingiber officinale, tortoise plastron, etc.Strong bones and musclesChinese Pharmacopoeia 2020[33]
Jiawei jianbu huqian wanCynomorium, Pleuropterus multiflorus, Clematis chinensis, Cupressus funebris, Panax ginseng, Hansenia weberbaueriana, etc.Curing of fall injuryJin Jian (Qing Dynasty, A.D. 1736)[34]
Gouqi wanCynomorium, Lycium chinense, Panax ginseng, Cupressus funebris, Angelica sinensis, Paeonia lactiflora, etc.Curing alzheimer diseaseShe Sheng Zhong Miao Fang (Ming Dynasty, A.D. 1550)[35]
Guilingji capsuleCynomorium, Talinum paniculatum, Lycium chinense, Syringa Linn, Achyranthes bidentata, Cistanche deserticola, etc.Curing cognitive dysfunctionChinese Pharmacopoeia 2020[36]
Jiawei buyin wanCynomorium, Achyranthes bidentata, Eucommia ulmoides, Amomum villosum, Angelica sinensis, Anemarrhena asphodeloides, etcCuring hyperthyroidismZhun Sheng Shang Han (Ming Dynasty, A.D. 1604)[37]
Jiajian buyin wanCynomorium, Cuscuta chinensis, Angelica sinensis, Paeonia lactiflora, Eucommia ulmoides, Achyranthes bidentata, etc.Curing perimenopausal syndrome of Yin deficiency typeDan Xi Xin Fa (Ming Dynasty, A.D. 1481)[38]

5. Phytochemistry

In recent years, a diverse range of potent chemical components have been isolated from various parts of the CSR plant. These components include flavonoids, triterpenoids, steroids, organic acids, sugars and glycosides, amino acids, and trace elements. Most of them have been extensively used in proprietary Chinese medicine and healthcare products. We classify the 98 compounds isolated and identified according to their types. The basic information and source areas of these compounds are summed up in Figure 3, while their structures can be seen in Figure 4, Figure 5, Figure 6, Figure 7, Figure 8, Figure 9, Figure 10 and Figure 11.

5.1. Flavonoids

A class of natural compounds with a parent nucleus structure of 2-phenylchromogen (flavone) are called flavonoids, which are the main active ingredients in CSR. Their molecular basis as the antioxidant [39] and anti-aging [40] activities of CSR have been widely proven, and CSR flavonoids have also been found to be effective in antibacterial activity [41].
Currently, a total of 27 types of flavonoids have been isolated from CSR sinensis. Phloridzin (1) [42], (−)-epicatechin (2), and naringenin (3) [9] were obtained from the 70% acetone extract and chloroform extract of stems. Ethyl acetate extract was isolated from (−)-catechin (4) [43]. Additionally, luteolin-7-O-glucoside (5) was isolated from the ethyl acetate fraction of the methanol extract derived from stems of CSR [16]. Two anthocyanins, procyanidin B1 (6) and procyanidin B6 (7), were extracted from the aqueous extract of stems of CSR chinensis [16].
The procyanidin B3 (8) was isolated and identified from the 70% acetone extract of fresh CSR stem through column chromatography. The identified compounds include catechin-(6′-8)-catechin (9), catechin-(6′-6)-catechin (10), epicatechin-(4β-8)-epicatechin-(4β-8)-catechin (11), epicatechin-(4β-6)-epicatechin-(4β-8)-catechin (12) and arecatannin A1 (13) [41]. Furthermore, dehydrodiconiferyl alcohol-9-O-β-D-glu-copyranoside (14), 3′,4′,5,7-tetrahydroxy-flavanone-2(S)-3′-O-β-D-glucopyranoside (15), luteolin-4′-O-β-glucopyranoside (16), astragalin (17), quercetin-3-O-rutinoside (18), naringenin-7-O-β-D-glucopyranoside (19), naringenin-5-O-β-D-glucopyranoside (20) was isolated from the ethyl acetate fraction of 95% ethanol extract obtained from fresh stems of CSR and identified through NMR analysis [4]. The compound naringenin-4′-O-β-pyranoglucose (21) was isolated from the n-butanol fraction of a 95% ethanol extract obtained from CSR whole grass [44].
Two anthocyanin pigments were isolated from a 95% ethanol extract of CSR inflorescences. Cyanidin 3-O-glucoside (22) was identified as the predominant pigment, accounting for 92%, while cyanidin 3-O-rhamnosylglucoside (23) was identified as the minor component, comprising 8% [45]. The compounds (+)-catechin (24), isoquercetin (25), rutin (26), and (−)-epicatechin-3-O-gallate (27) were isolated from ethanol extract of CSR inflorescences [46] (Table 2).

5.2. Terpenoids

Terpenoids, composed of isoprene polymers as the basic skeleton, exhibit diverse structures and functions in different plants. These compounds influence plant odor and flavor. Therefore, terpenoids have significant application value in fields such as natural drugs and spices.
The studies have demonstrated that terpenoids are the secondary metabolites of CSR. Twelve terpenoids were isolated, which were as follows. Malonyl ursolic acid hemiester (28), ursolic acid (29), acetyl ursolic acid (30), oleanolic acid (31), betulinic acid (32) [16], and malonyl oleanolic acid hemiester (33) [10] were isolated from dichloromethane extract of CSR stem. The glutaryl ursolic acid hemiester (34), oxalyl ursolic acid hemiester (35), succinyl ursolic acid hemiester (36), and ursolic acid methyl ester (37) were isolated from the ethyl acetate extract of CSR stem [47]. Additionally, a diterpenoid compound 3β, 28-dihydroxyoleana-11,13(18)-diene (38) was isolated from the ethyl acetate fraction of a 95% ethanol extract obtained from the CSR stem [48]. The isolation of maslinic acid (39) was achieved from the aqueous extract of CSR [49].
The terpenoids discovered in CSR malonyl ursolic acid hemiester, ursolic acid, acetyl ursolic acid, and malonyl oleanolic acid hemiester are commonly occurring triterpenes that can also be found in other plant species (Table 3).

5.3. Steroids

The tetracyclic structure of cycloalkyl polyhydrophenanthrene is the parent nucleus of this class of compounds known as steroids. There are several substances found in fauna and flora, including cholesterol, steroid hormones (such as estrogen, androgen, and adrenal corticosteroids), and sterols. These substances play a crucial role in physiological functions with a wide range of biological functions.
Ten steroid compounds were isolated from CSR was achieved. The compounds 5α-Stigmast-9(11)-en-3β-ol (40) and 5α-Stigmast-9(11)-en-3β-ol tetracosatrienoic acid ester (41) were isolated from ethyl acetate extract of stems of CSR [12]. Daucosterol (42) and β-sitosterol (43) were isolated from the ethyl acetate fraction of a 95% ethanol extract obtained stem of CSR [13]. The β-sitosteryl oleate (44), β-sitosteryl glucoside (45), and β-sitosteryl glucoside 6′-O-aliphatates (46) were isolated from the dichloromethane extract of CSR stem [16]. Furthermore, β-sitosterol palmaitate (47) was isolated from the chloroform extract [50]. The identification and analysis of campesterol (48) and γ-sitosterol (49) were conducted using Gas chromatography–mass spectrometry (GC-MS) in addition to other techniques [51] (Table 4).

5.4. Saccharides and Glycosides

Saccharides are one kind of important bioactive compounds in CSR, which exhibit diverse biological and pharmacological activities. These two polysaccharides consist of galactose, glucose, arabinose, rhamnose, mannose, ribose, and uronic acid. Among these components, the latter two ingredients account for 10.7% and 10.5%, respectively [52]. By report, a water-soluble heteropolysaccharide called CSPA, which is a heteropolysaccharide composed of arabinose (Ara), glucose (Glu), and galactose (Gal), was isolated from CSR. It has a molecular weight of 1.394 × 105 Da. The chemical structure consisted of the following units: “→3)-α-araf-(1→3)-α-d-glcp-(1→4)-α-d-GalpA6Me-(1→” [53]. The polysaccharide extracted from CSR was fractionated into three components, namely CSG-F1, CSG-F2, and CSG-F3. CSG-F1 (yield of 21%) exhibited an average molecular weight of approximately 2.4 × 105 Da and primarily consisted of galactose, glucose, arabinose, and rhamnose. Similarly, the purified CSG-F2 (yield of 14%) displayed an average molecular weight of around 1.3 × 105 Da and contained galactose, glucose, arabinose, rhamnose, and ribose as its main constituents. Lastly, the purified CSG-F3 (yield of 37%) had an estimated average molecular weight of about 1.9 × 105 Da and glucose, arabinose, rhamnose, ribose, and mannose [54].
The isolation of thirteen sugars and glycosides from CSR was achieved. Glucose (50) was isolated from the chloroform extract of CSR stem [9]. Zingerone 4-O-β-D-glucopyranosid (51) [10] was isolated from the dichloromethane extract of CSR stem. Three fructosides were isolated from the ethyl acetate extract. The structures of n-butyl-β-D-fructofuranoside (52) [55], n-butyl-α-D-fructofuranoside (53) [11], and n-butyl-β-D-fructopyranoside (54) [56] were determined using spectroscopic methods. The compound piceid (55) [16] was obtained from the ethyl acetate fraction of the methanol extract, while coniferin (56) and isoconiferin (57) [16] were isolated from the n-butanol fraction. The isolation of adenosine (58) [16] was achieved from the n-butanol fraction of the CSR methanol extract. The compounds (−)-isolariciresinol 4-O-β-D-glucopyranoside (59) and (7S,8R)-dehydrodiconiferyl alcohol 9′-β-glucopyranoside (60) were isolated from the aqueous extract [42]. The compound nicoloside (61) [42] was isolated from the aqueous fraction of the methanol extract obtained from CSR. Furthermore, songaricumone A (62) was isolated from the ethyl acetate fraction of 95% ethanol extract obtained from fresh stems of CSR and identified through NMR analysis [4] (Table 5).

5.5. Organic Acids and Organic Acid Ester

Organic acids and esters can serve as carriers for drug delivery systems, improving the physical stability and solubility of drugs, regulating lipid metabolism, participating, and regulating various physiological processes as signaling molecules, and having anti-inflammatory and antibacterial effects.
One of the important active ingredients of CSR is an acidic organic compound called organic acid. At present, 17 distinct types of organic acids and organic acid ester have been successfully isolated from CSR. Protocatechuic acid (63), gallic acid (64), n-butyric acid (65) [13], and 4-methoxycinnamic acid (66) [48] were isolated from the ethyl acetate fraction of a 95% ethanol extract obtained from stems of CSR. The compounds p-hydroxybenzoic acid (67) [42], methyl protocatechuicate (68) [42] and p-hydroxybenzoic acid (69) [16], were isolated from the ethyl acetate fraction of the methanol extract. The compounds 3,4-dihydroxybenzoic acid ethyl ester (70) [57], 4-hydroxyphenethyl 2-(4-hydroxyphenyl) acetate (71) [48], and stearic acid α-monoglyceride (72) [13] were isolated from the ethyl acetate fraction of a 95% ethanol extract obtained from stems of CSR. The water parts are separated by succinic acid (73) [43]. The compounds ferulic acid (74) [58] were isolated from a 70% ethanol extract of stems of CSR. Additionally, gentisic acid (75), palmitic acid (76), and 3,4-dihydroxyphenethyl acetate (77) were obtained from a water extract [49]. The vanillic acid (78) [44] was extracted from an aqueous solution of 95% ethanol extract from whole grass, while the capilliplactone (79) [59] was isolated from the ethyl acetate fraction. The structure was determined using spectroscopic techniques (Table 6).

5.6. Phloroglucinol Adducts

A type of compound formed by three hydroxyl groups (-OH) to replace the hydrogens at the 1,3,5 positions in benzene, is called phloroglucinol. It is a drug widely used in the medical field. Belonging to the class of phenobarbital drugs, it has pharmacological effects such as sedation, hypnosis, anticonvulsant, and antianxiety. It is considered an important drug that can be used to treat various diseases and symptoms.
Six types of phloroglucinol compounds were isolated from CSR. The identification of three phloroglucinol compounds was achieved from the 70% acetone extract of fresh stems of CSR using LC-MS and HPLC retention time analysis. These compounds were identified as epicatechin-(4β-2)-phloroglucinol (80), epicatechin-3-O-gallate-(4β-2)-phloroglucinol (81) and catechin-(4α-2)-phloroglucinol (82) [41]. Two new compounds were recently isolated from a degraded mixture of cynomoriitannin and identified as cynomoriitannin-phloroglucinol A (83) and cynomoriitannin-phloroglucinol B (84) based on spectroscopic analyses [41]. Phloroglucinol (85) was isolated from the stem’s aqueous extract of CSR [49] (Table 7).

5.7. Other Compounds

The qualitative and quantitative analysis of amino acids revealed the presence of 20 common amino acids in CSR, which serve as essential nutritional elements for the human body [60]. Furthermore, volatile components [61], trace elements [62], and tannins [63] play a significant role in the pharmacological activity of CSR.
Mannitol (86) was isolated from the aqueous extract [49]. Protocatechualdehyde (87), chrysophanol (88), emodin (89), and physcion (90) were isolated from the 70% ethanol extract [58]. The compounds (−)-lariciresinol (91) and 4-methylcatechol (92) [57] were isolated from the ethyl acetate fraction of a 95% ethanol extract obtained from the CSR stem. Additionally, the following compounds were also identified: 4β-(L-cysteinyl)-catechin (93), 4β-(L-cysteinyl)-epicatechin (94), 4β-(L-cysteinyl)-epicatechin 3-O-gallate (95) three cysteine conjugates [64], 4β-(L-acetylcysteinyl)-epicatechin (96), 4β-(L-acetylcysteinyl)-epicatechin 3-O-gallate (97), 4β-(L-acetylcysteinyl)-epiafzelechin (98) three acetylcysteine conjugates [64], and edible reagents from CSR were isolated and purified. The structures were elucidated via a combination of NMR and mass spectrometry techniques [64] (Table 8).

6. Pharmacology

Scholars have combined traditional Chinese medicine with modern medicinal chemistry to explore the biological activity of chemical components in traditional Chinese medicine. Alcohol and water extracts exhibit significant pharmacological activities, including anti-oxidant and anti-tumor effects, among others (Figure 12 and Figure 13).

6.1. Anti-Tumor Effects

Inducing apoptosis serves as a method for preventing and treating tumors as it plays an essential role in tumor progression [65]. Cancer stem cells are inhibited from proliferating and dying when exposed to CSR. It can be used to treat malignant tumors such as breast cancer, leukemia, colon cancer, and others.

6.1.1. Anti-Cancer

There are four breast cancer cell lines inhibited by CSR extracts and its ethyl acetate extraction site, including MDA-MB-231 [15,66], MCF-7 [15,66], MB468 [15], and 4T1 [15]. Furthermore, CSR extract induces Foxo3 expression in apoptosis and prevents the transition from G1 to S phases [15]. It has been found that chloroform and ethyl acetate extraction sites from the CSR ethanol extract are capable of inhibiting the proliferation of the colon adenocarcinoma cell line Caco-2 [7]. In cell research for cervical cancer treatment, Cynomrium songaricum polysaccharides (CSP) inhibit proliferative activity in HeLa cells [67]. A further study showed that both methanol extract and anthocyanin 3-O-glucoside from CSR inhibited KBWT cell proliferation in a dose-dependent manner [68]. By inhibiting telomerase reverse transcriptase (TERT) mRNA, CSP induced apoptosis in A549 cells [69]. Methanol extract and aqueous extract from CSR inhibited the growth of B16 cells, which are used for studying skin cancer in humans [15]. Further, CSR ethyl acetate extract inhibited both LNCaP and HepG2 cells, showing that it may have therapeutic effects on prostate cancer and liver cancer [66]. Research has shown that the anticancer ingredients in CSR are concentrated in the ethyl acetate extraction site, and it may be related to activating and enhancing autophagy processes in cells to trigger. In autophagy and apoptotic cell death, mitochondrial-related proteins Bcl-2/adenovirus E1B 19 kDa-interacting protein 3 (BNIP3) and Bcl-2/adenovirus E1B 19 kDa protein-interacting protein 3-like (BNIP3L) play a critical role [66].

6.1.2. Leukemia

CCRF-CEM and CCRF-SB cells were inhibited by methanol extract and anthocyanin 3-O-glucoside from CSR [68]. Similarly, mitochondrial pathways modulate caspase-3 activity. Therefore, CSR ethanol extract causes apoptosis in leukemia cells by causing apoptosis in HL-60 cells [70].
The above studies indicate that CSR has a certain inhibitory effect on two types of tumor cells, cancer, and leukemia. In cancer, it inhibits the growth of cancer cells by inducing the expression of Foxo3 and inhibiting telomerase reverse transcriptase mRNA to activate mitochondrial-related proteins BNIP3 and BNIP3L. Regulating caspase-3 activity through the mitochondrial pathway in leukemia induces cell apoptosis. In contrast, there is more research data on adenocarcinoma and less research on leukemia. However, it cannot be concluded with certainty that CSR has a better therapeutic effect on cancer than on leukemia. Therefore, more in-depth research is still needed (Table S1, Supplementary Materials).

6.2. Anti-Oxidation Function

Different parts of CSR have different antioxidant activities when extracted from methanol. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radicals are best scavenged in the central part, hydroxyl radicals are best inhibited in the lower part, and superoxide anions are highly resisted in the upper part [71]. Multiple solvent extracts of CSR exhibit antioxidant activity. A methanol extract of the CSR and an ethyl acetate extraction site strongly inhibit superoxide anions [72,73]. DPPH radicals, 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radicals, and hydroxyl radicals are also scavenged by the aqueous extract and ethyl acetate extraction site [4]. Additionally, the aqueous extract was able to scavenge DPPH free radicals and inhibit superoxide anion formation [74].
Different extracts exhibit significantly different antioxidant and radical scavenging properties. CSR aqueous extract scavenges DPPH free radicals and nitrates more effectively than ethanol extract. In contrast, ethanol extract inhibits xanthine oxidase (XO) and superoxide dismutase (SOD) more effectively than aqueous extract [75].
To examine the categories of substances with superior antioxidant effects, compounds of the same type extracted from CSR were compared to their antioxidant activity. This was performed to clarify the strong antioxidant activity of CSR extract. Within a certain concentration range, CSP exhibits effective scavenging ability against superoxide anion radicals, DPPH radicals, and hydroxyl radicals [6]. CSR flavonoids also scavenge DPPH and hydroxyl radicals [76].
Crude polyphenols exhibited significantly higher antioxidant activity than crude polysaccharides when measured against DPPH radicals, ABTS free radicals, and crude polysaccharides in CSR [77]. According to another study, microwave-extracted procyanidins exhibited superior scavenging activity against DPPH and hydroxyl free radicals [39].
The main antioxidant component in the CSR ethyl acetate extraction site is catechin, which was isolated from protocatechuic acid, gallic acid, and catechins [78]. The aqueous extract of CSR was separated into catechin, epicatechin, and olive saponin to determine the DPPH free radical scavenging capacity [79].
In vivo experiments were used to verify the CSR extract’s significant antioxidant activity. CSR extracts (0.22 g/kg, 0.44 g/kg, 0.88 g/kg) can enhance the serum DPPH free radical scavenging ability of KM mice, and reduce oxidative damage caused by free radicals and lipid peroxides [80].
Some in vivo and in vitro experiments have shown that the antioxidant components in CSR exert antioxidant effects by clearing free radicals, as well as inhibiting XO and SOD, etc. The antioxidant activity of CSR is one of its main functions, which can slow down the oxidative state of the body and fight against diseases (Table S2, Supplementary Materials).

6.3. Anti-Aging Effects

Several studies have demonstrated the anti-aging effects of CSR through a variety of mechanisms. According to reports, adding CSR to the diet can extend the average and maximum lifespans of adult female flies. Ethanol extract of CSR suppresses age-related learning disabilities in elderly flies by reducing hydrogen peroxide levels and increasing antioxidants, extending their lifespan, improving mating readiness, increasing fertility, and inhibiting age-related learning disabilities [81]. A transcriptome sequencing study found that CSR extract impacted wild-type Caenorhabditis elegans aging. The lifespan of Caenorhabditis elegans was extended and motor abilities were enhanced by ethyl acetate extract (0.4 mg/mL). Multiple pathways and genes collaborate to produce the effects of the ethyl acetate extract [82]. Various research results have shown that extracts, CSP, and preparations from CSR can delay aging by inhibiting telomere length shortening [83], enhancing telomerase activity [84], improving immune function [85,86,87], inhibiting neuronal apoptosis [17,84], improving hippocampal CA1 neurons [88], enhancing antioxidant capacity [17,40,85,87,89].
The aqueous extract of CSR can also improve the energy metabolism of liver mitochondria in aging model KM mice. It can also alleviate free radical damage to mitochondrial membrane structure and function and play a role in delaying aging [90].
These findings not only reveal the potential of the polysaccharide and extract in combating aging but also lay the groundwork for future clinical research. It would be beneficial to further investigate the chemical composition of CSR and the mechanism underlying anti-aging as well as their safety and effectiveness to offer novel insights and possibilities for delaying the aging process in the future (Table S3, Supplementary Materials).

6.4. Anti-Fatigue and Anti-Hypoxia Activities

The aqueous extract and ethanol extract of CSR are responsible for its anti-fatigue properties. By lowering the lactate index [91], inhibiting amino acid protein breakdown, and increasing glycogen reserves [92,93,94], they can improve energy metabolism. It also possesses the ability to increase the level of cyclic adenosine monophosphate (cAMP), reduce cyclic adenosine monophosphate/cyclic guanosine monophosphate (cAMP/cGMP) ratio [18], improve free radical metabolism [94,95]. In addition, CSR flavonoids (CSF) reduce MAO activity and reactive oxygen species (ROS) levels by improving free radical metabolism [96,97,98].
Oxygen deficiency can cause abnormal tissue metabolism, function, and morphology. The main cause of death is hypoxia of the brain and heart. CSR aqueous extract has positive atmospheric pressure anti-hypoxia and anti-acute cerebral ischemia and hypoxia effects [99], which increases blood hemoglobin content and enhances oxygen-carrying function [100]. As well as reducing brain edema, it increases myocardial protein content [101].
CSR exhibits remarkable anti-fatigue and anti-hypoxia properties. Research on anti-fatigue effects focuses on its active ingredients, such as water extract, ethanol extract, and flavonoids. Currently, hypoxic resistance studies are primarily focused on CSR water extract. Developing highly potent and pharmaceutically viable compounds from CSR for anti-fatigue and anti-hypoxia purposes will require further investigation (Table S4, Supplementary materials).

6.5. Effects on Nervous System

Ethyl acetate extract and methanol extract are both effective against Aβ25–35, hypoxanthine/xanthine oxidase (HPX/XO) [102], Xanthine dehydrogenase/xanthine oxidase (XDH/XO) [72] induced SK-N-SH cells have protective effects. Among them, ethyl acetate extract is more effective against Amyloidβ-Protein 25–35 (Aβ25–35) and has an anti-Starosporin-induced injury effect [73]. CSP and ethyl acetate extraction sites of CSR can protect PC12 cells against damage by H2O2 [103] and Aβ25–35 [104]. Ethyl acetate extract has cytotoxicity to Neuro2A cells (EC50 = 116 mg/L) and increases the expression of synaptophysin through the mitogen-activated protein kinases (MAPK) pathway [105]. In another study, the methanol extract of CSR inhibits Aβ25–35 induced phosphorylation of dynamin-related protein 1 (Drp1) at Ser637 in HT22 cells and reduced the expression of Fission 1 Protein (Fis1) in H2O2 induced model for the treatment of Alzheimer’s disease (AD) [106].
Based on neuroprotective effects at the cellular level, scholars have further explored them through animal models. The ethyl acetate fraction of CSR improves the behavior of C57BL/6 male mice by reducing mitochondrial dynamics imbalance. It also downregulated the expression of the Drp1 protein and upregulated the expression of Optic Atrophy 1 (OPA1) and Mito Fusin 1 (MFN1) proteins [107]. It also improves the spatial memory and learning ability of AD model mice by regulating fecal microbiota disorder [108]. In the ovariectomized Sprague–Dawley (SD) rat model, it increased the expression of Growth-Associated Protein 43 (GAP-43) protein in the hippocampus [109], regulated the MAPK pathway, increased the expression of phosphorylation-cAMP response element-binding protein (p-CREB), and decreased the expression of p38, thereby promoting the survival and repair of hippocampal neurons.
Other studies have shown that CSR ethyl acetate extract increases the expression levels of synaptic plasticity-related proteins Syn and postsynaptic density protein-95 (PSD-95) [110] while upregulating the protein expression levels of phosphor-extracellular regulated protein kinases 1/2 (P-Erk1/2) and P-CREB in the MAPK/ERK1/2 signaling pathway [111]. It increases the effect of Long-term Potential (LTP) in Morris water maze and neuroelectrophysiology, further improving cognitive dysfunction in chronic stress Institute of Cancer Research (ICR) mice after ovariectomy [112].
The ethanol extract of CSR increased cAMP response element-binding protein /Brain-Derived Neurotrophic Factor (CREB/BDNF) expression in ovariectomized SD rats by inhibiting the p38MAPK/ERK pathway [113]. It also reduced serum corticosterone levels, increased the expression of BDNF mRNA in this region, promoted the proliferation of mouse dentate gyrus cells and differentiation of neuroblasts, enhanced the potential for hippocampal plasticity in male C57BL/6J mice [114], and thus achieved neuroprotective effects on the nerves.
The aqueous extract of CSR has a significant improvement effect on the learning and memory of scopolamine-induced KM male mice. Its mechanism may be related to reducing oxidative stress in brain tissue [115].
In Wistar male rats, through upregulating the Brain-Derived Neurotrophic Factor/Tyrosine Kinase receptor B (BDNF/TrkB) signaling pathway, enhancing cognitive function, increasing acetylcholine (ACH) content in the central cholinergic system, inhibiting cell apoptosis, and enhancing synaptic plasticity, CSF improves the AD model induced by Aβ1–42 [116]. In addition, CSF inhibits oxidative stress and inflammatory reactions. It can also downregulate the expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, ROS, and NOD-like receptor thermal protein domain associated protein 3 (NLRP3) in the hippocampus, exerting neuroprotective effects [117].
The main component of CSR, ursolic acid, at a concentration of 5–15 µM, can effectively protect SD rat hippocampal neurons from damage induced by kainic acid by regulating α-amino-3-hydroxy-5-methy1-4-isoxazole propionic acid (AMPA) receptors, protecting mitochondria, and reducing free radical generation [118,119].
In summary, the neuroprotective active ingredients are mainly concentrated in the methanol, ethanol, and ethyl acetate extracts of CSR. However, the main components that play a key neuroprotective role are not yet clear because of the complex components in CSR extract. Therefore, future studies should explore compounds that play a major role in protecting the nervous system (Table S5, Supplementary Materials).

6.6. Effects on Reproductive System

In geriatrics, benign prostatic hyperplasia (BPH) is a common genitourinary disorder characterized by prostate gland enlargement and urinary dysfunction [120]. There is an inhibitory effect of ethanol extract of CSR (2.5 mg/mL) on testosterone 5α-reductase [121]. Moreover, it interferes with estrogen/androgen signals to inhibit prostate hyperplasia in Wistar rats [58] and improves the disorder of prostate epithelial cells and abnormal proliferation of connective tissue in Wistar rats with BPH model, inhibiting Proliferating Cell Nuclear Antigen (PCNA), Androgen Receptor (AR), and estrogen receptor α (Erα) Protein expression while promoting estrogen receptor β (ERβ) Protein expression while promoting ERβ Protein expression [122]. Meanwhile, Wistar male rat protein expression of prostate AR, ERα/β, and 3-oxo-5-alpha-steroid 4-dehydrogenase 1/2 (SRD5A1/2) were regulated to inhibit BPH [123]. Additionally, CSR aqueous extract inhibits prostate hyperplasia, increases SOD and glutathione (GSH) activities, decreases malondialdehyde (MDA) content, and significantly reduces prostate wet weight and prostate index by improving testosterone propionate-induced oxidative stress levels [124].
In vitro experiments, Luteolin, Gallic acid, Ferulic acid, Protocatechualdehyde from CSR suppressed BPH by downregulating the expression of AR and ERα in BPH-1 cells and upregulation ERβ expression [123]. CSRs containing luteolin, epicatechin, and epicatechin gallate all improve the contractility of Wistar male rats’ bladder detrusors [125].
Infertility in men is complex and multifactorial, with idiopathic infertility accounting for approximately 30% of cases [126]. It has been shown that CSR improves sexual hormone levels as a kidney tonifying traditional Chinese medicine [113]. Under the intervention of CSR aqueous extract, serum testosterone and Follicle-stimulating Hormone (FSH) levels are reduced, and interstitial cell-stimulating hormone (ICSH) levels are increased to directly affect the spermatogenic effect of immature seminiferous tubules of Wistar rats [127]. It can also promote the secretion of testosterone in SD rats and inhibit abnormal secretion of FSH and Luteinizing hormone (LH) by regulating gonadal hormone levels [128]. Glial Cell Line-derived Neurotrophic Factor (GDNF) production in testes of SD rats and undifferentiated spermatogonia proliferation stimulates, increases testosterone levels, and improves sperm motility [129]. Relieving sperm damage and serum testosterone levels are increased through the MAPK-3-mediated GDNF signaling pathway, thereby enhancing sperm motility [130].
In addition, enhancing sperm production in Wistar rats and upregulating the expression pathway of GDNF in the testes to improve male fertility [131], enhancing sperm production in golden hamsters, and blocking the impact of short photoperiod on reproductive function [132] by CSR aqueous extract.
In summary, active compounds from CSR that inhibit BPH mainly exist in its ethanol extract, while the active ingredients that promote spermatogenesis are mainly concentrated in the aqueous extract, which has been proven to have good therapeutic effects in treating male infertility (Table S6, Supplementary Materials).

6.7. Anti-Virus

Despite a significant increase in the number of approved antiviral drugs, these existing drugs are not always effective or well tolerated. It is becoming increasingly common for viruses to develop drug resistance. As of now, many polysaccharides have been approved as drugs as independent or major bioactive components [133]. The methyl thiazolyl tetrazolium (MTT) method was used to detect the toxicity of CSP on MT-4 cells, which showed that only sulfated polysaccharides (SCSP-M, SCSP-1, SCSP-2) are anti-HIV. Due to the interaction between sulfated polysaccharides and poly L-lysine, sulfated polysaccharides have antiviral properties [134].
In addition to the CSP, the triterpenoids contained in CSR also have antiviral activity. Ursolic acid, half ursolic malonate, malonyl oleanolic acid hemiester [10], acetyl ursolic acid, and condensed tannin extracted from CSR all have the function of inhibiting human immunodeficiency virus (HIV) protease [16]. Furthermore, triterpenoids in CSR also have inhibitory activity against hepatitis C virus (HCV) protease, with malonyl ursolic acid hemiester having the maximum inhibitory effect [47].
The main components of CSR are polysaccharides and triterpenoids, which are potentially useful for developing antiviral drugs. Additionally, it is worth noting that the antiviral efficacy of CSR has predominantly been tested in vitro with limited reports on its in vivo effects. Consequently, the precise mechanism by which CSR is antiviral remains unclear. Future studies should explore this aspect further to uncover the antiviral mechanism of CSR and establish solid foundations for its application (Table S7, Supplementary Materials).

6.8. Anti-Diabetic Properties

CSP as one of the pivotal active constituents in CSR, exhibits significant therapeutic effects on several diseases. Consequently, CSR is being considered a potential candidate for the development of novel anti-diabetic drugs [135]. Oral administration of CSR water-soluble polysaccharide (CSPA) significantly reduced the blood glucose level, glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, blood urea nitrogen, creatinine activity in streptozotocin (STZ) induced diabetes model rats, effectively increased the serum insulin level and liver glycogen content and promoted the recovery of pancreatic islet cells in the pancreas to near normal levels [53]. CSP (300 mg/kg) can upregulate the expression of protein kinase B (AKT) and endothelial nitric oxide synthase (eNOS), and downregulate tumor necrosis factor α (TNF-α) expression [136]. It can also regulate phospholipid metabolism, including phosphatidylcholine, Lys phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin to play a role in the treatment of diabetes [137].
In addition to polysaccharides, the flavonoids and their amino acid derivatives contained in CSR can also exert hypoglycemic effects. Flavan-3-ol derivatives prepared from CSR and other reagents, including 3 cysteine conjugates and 3 acetylcysteine conjugates, were found to have significant effects on α-glucosidase, sucrase, and maltase have inhibitory effects [64]. Furthermore, the flavane-3-ol oligomer and compound Pentamers (pentamer) in the stem have inhibitory effects on α-Glucosidase has inhibitory effects [138].
The investigation of CSR’s anti-diabetic activity is limited to in vitro and in vivo experiments. It plays an anti-diabetes role by regulating blood sugar levels, improving insulin sensitivity, protecting islet cells, controlling the risk of complications, etc. While these studies have demonstrated some anti-diabetic effects of CSR, further clinical trials are necessary to confirm its efficacy and safety for human use (Table S8, Supplementary Materials).

6.9. Anti-Osteoporosis Effect

A few studies have demonstrated the favorable anti-osteoporotic effects of CSR. After screening the methanol and water extracts of 60 natural medicinal herbs, it was found that the methanol extract of CSR has a stimulating effect on the proliferation ability of osteoblast UMR106 and an inhibitory activity on osteoclast formation [139]. CSP (100 μg/mL) induces osteogenic differentiation in MC3T3-E1 cells by activating Phosphatidylinositide 3-kinases/AKT/glycogen synthase kinase-3β/β-Catenin (PI3K/AKT/GSK3 β/β-Catenin) pathway and upregulates mRNA, PI3K, phos-pho-phosphatidylinositide 3-kinases (p⁃PI3K), AKT, phospho-protein kinase B (p⁃AKT), GSK3β, phosphor-glycogen synthase kinase-3β (p⁃GSK3β), β⁃catenin protein expression [140]. Ethanol extract of CSR can promote the differentiation of osteoblasts from MC3T3-E1 while inhibiting osteoblast apoptosis, upregulating the expression of Bax and caspase-3, and downregulating the expression of B-cell lymphoma-2 (Bcl-2) [141]. CSR aqueous extract containing serum can promote the proliferation and differentiation of MC3T3-E1 osteoblasts, increase alkaline phosphatase (ALP) activity, and increase the number of calcified nodules [142].
In in vitro experiments, CSP was administered to ovariectomized SD rats. The results express that CSP can increase the osteoclastogenesis inhibitory fac-tor/Receptor Activator for Nuclear Factor-κB Ligand (OPG/RANKL) ratio, inhibit osteoclast activity by activating the OPG/Receptor Activator for Nuclear Factor-κB (RANK)/RANKL signaling pathway, regulate osteocalcin levels to reduce bone turnover rate, restore the balance between bone formation and bone resorption, reduce bone loss, increase bone density, improve tibial biomechanical properties, reduce bone fragility and fracture risk, and promote osteoblast differentiation [143].
The ethanol extract of CSR can accelerate bone formation, inhibit bone resorption, and alleviate oxidative stress. It can also increase ALP levels in ovariectomized SD rats and reduce the levels of bone resorption-related biomarkers tartrate-resistant acid phosphatase (TRAP), Cathepsin K, and DPD [144]. At the same time, it can also mediate PI3K/AKT and Nuclear Factor-κB (NF-κB) through RANKL/RANK/ TNF receptor-associated factor 6 (TRAF6) pathway to play an anti-osteoporosis role [145].
To summarize, the anti-osteoporotic effect of CSR is primarily attributed to its extract and polysaccharide constituents. By increasing bone density, slowing down the process of osteoporosis, enhancing the resistance to fractures, reducing the risk of fractures, improving blood circulation, and increasing the nutrient supply of bones, it plays its role. However, there are currently no mechanisms of action for specific components. Further investigations are still required to clarify the underlying anti-osteoporosis mechanisms associated with the active constituents of CSR (Table S9, Supplementary Materials).

6.10. Liver Protection

Among its many functions, the liver plays a crucial role in immunity, metabolism, detoxification, and digestion. Fibrosis of the liver is an injury-repair response, which can be partially reversed. However, persistent damage can lead to chronic inflammation, which triggers the formation of liver fibers [146].
In order to effectively treat patients with chronic liver disease, liver fibrosis must be halted or slowed down [147]. Blood levels of glutamic oxalate transaminase (GOT) and glutamic pyruvate transaminase (GPT) increase when the liver is damaged. In liver injury induced by Streptozocin (STZ) in Wistar rats, CSPA (200 mg/kg, 150 mg/kg) reduces levels of GOT and GPT [53]. By increasing white blood cell (WBC) levels, hematocrit (HCT) levels, red blood cells (RBCs), mean corpuscular volumes (MCVs), and red blood cell distribution width (RDW) levels in the blood cells of SD male rats induced by carbon tetrachloride. CSR extract regulates the transforming growth factor β1 (TGF-β1) expression [148] and increases levels of WBC, HCT, RBC, MCV, and RDW in the blood cells of SD male rats induced by carbon tetrachloride, to impact blood cell typing and alleviate symptoms of liver fibrosis [149]. Furthermore, it can also reduce the liver’s exposure to the inflammatory factors TGF-β1, TNF-α, and interleukin 1 (IL-1) stimulation, thereby reducing liver fibrosis [150]. CSR aqueous extract (3.5 g/kg) alleviates the lipid peroxidation damage caused by free radicals attacking the liver cell membrane of male Wister rats and protects the liver tissue from normal physiological operation [92].
The use of 60% ethanol extract from CSR has been found to reduce serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydro-genase (LDH), and laminin (LN) in KM male mice induced by carbon tetrachloride. Additionally, the extract of CSR reduced the content of Hyp and MDA in liver tissue, while increasing SOD and GSH. By increasing the body’s antioxidant level and scavenging free radicals, reducing collagen fiber production, and reducing extracellular matrix deposition, the extract of CSR protects the liver [151].
HCY2 and ursolic acid isolated from the ethanol extract of CSR can enhance mitochondrial function and glutathione antioxidant status in liver tissue, inhibit plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities, and protect SD female rats from carbon tetrachloride damage [152]. CSF enhances the activity of SOD and Glutathione peroxidase (GSH-Px) in formaldehyde-induced T6 cells [153], reduces the protein concentration and MDA content of H2O2-induced damage to T6 cells, increases the expression level of nitric oxide synthase (NOS) protein [154], and has a protective effect on oxidative damage to T6 cells.
Along with the current increasing demand for hepatoprotective drugs, CSR has demonstrated promising potential in the field of drug development for liver protection. However, due to the intricate physiological functions of the liver, further investigations are required to elucidate more specific mechanisms underlying hepatoprotection. Additionally, it is also imperative to conduct comparative analyses of CSR constituents to assess their respective hepatoprotective abilities (Table S10, Supplementary Materials).

6.11. Other Pharmacological Effects

6.11.1. Intestinal Effects

A specific effect of CSR is to promote intestinal peristalsis, facilitate bowel movement, and maintain intestinal moisture. CSP (14.28 mg/kg, 28.57 mg/kg, 57.14 mg/kg) counteracted atropine’s inhibitory effect on intestinal peristalsis in KM mice by modulating parasympathetic nervous system function, reducing phenol red residue, and increasing intestinal propulsion rates [155]. Comparing the effects of aqueous extract with ethyl acetate, methanol, and the aqueous extraction site of CSR on intestinal defecation in KM mice, it was observed that the aqueous extract (3.9 g/kg) showed significant activity [43]. As demonstrated by the aqueous extracts of CSR (0.01 g/mL, 0.015 g/mL, 0.02 g/mL), the CSR augments smooth muscle contraction frequency while attenuating smooth muscle contraction amplitude in New Zealand white rabbits, resulting in mild “intestinal moistening and purging” effects [156].

6.11.2. Mitigate Obesity

Ursolic acid (UA), an active component of CSR, HCY2 significantly reduced both body weight gain and fat pad weight in ICR mice [157]. Furthermore, the expression of mitochondrial uncoupling protein 3 in skeletal muscle can be increased by ursolic acid through the regulation of the Adenosine phosphate-activated protein kinase/peroxisome proliferator-activated receptor γ coactivator-1 (AMPK/PGC1) pathway, thereby potentially contributing to the treatment of obesity [158].

6.11.3. Renal Protective Effects

With the aggravation of diabetes and the side effects of hypoglycemic drugs, kidney damage is gradually caused. Serum levels of blood urea nitrogen (BUN) and creatinine (Cr) are significantly increased, which is considered to be an important indicator of renal dysfunction. HCY2 (0.5 mg/kg, 1.0 mg/kg) and ursolic acid (0.35 mg/kg, 0.70 mg/kg), derived from the CSR, resulted in a reduction in BUN and Cr levels and provided protection against gentamicin-induced nephrotoxicity in female SD rats [152]. CSPA (200 mg/kg, 150 mg/kg) in vivo significantly reduces the levels of BUN and Cr, thereby ameliorating renal dysfunction in streptozotocin-induced Wistar rats [53]. The CSP concentrations (0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL) indirectly attenuated H2O2-induced apoptosis of VERO cells by suppressing caspase-3 activity in vitro, indicating the potential of CSR for the prevention and treatment of kidney-related diseases [159].
In summary, CSR protects kidney function from further damage by improving renal blood circulation, anti-fibrotic, antioxidant, and anti-inflammatory effects. For acute kidney injury, renal protection can promote the repair and regeneration of kidney tissue, reduce oxidative damage and inflammatory reactions, and help alleviate the degree of kidney injury and restore kidney function. For chronic renal failure, renal protection can delay the progression of the disease and reduce the loss of renal function.

6.11.4. Immune System Modulation

Studies have demonstrated that CSR exine levels effectively inhibit the autoimmune antibodies and enhance humoral immune function, thereby improving overall immune competence in the body.
The 75% alcohol extract (0.1 g/kg, 0.2 g/kg, 0.4 g/kg) and aqueous extract (0.18 g/kg, 0.36 g/kg, 0.72 g/kg) of CSR significantly augmented the thymus index and spleen index in immunosuppressed KM mice while also enhancing phagocytic function within the immune system. They promoted hemolysin antibody production and increased serum levels, interferon-γ (IFN-γ), and TNF-α secretion, thereby bolstering both humoral and cellular immunity responses; notably, aqueous extract to the ethanol extract [14]. The aqueous extract of CSR part Ⅲ (300 mg/kg) demonstrated a protective effect on BALB/C mice immunosuppressed by cyclophosphamide (CTX). It enhanced the phagocytic capacity of macrophages towards foreign bodies and resulted in an elevation in serum, effectively improving the humoral immune function of mice [160]. In addition to the immunomodulatory effects observed with CSR aqueous extract and ethanol extract, CSP exhibits significant immunomodulatory effects in vitro experiments. Specifically, CSP polysaccharide demonstrates remarkable potential as it promotes the proliferation and enhances the phagocytic activity of RAW264.7 macrophages at concentrations ranging from 25 to 400 μg/mL. Moreover, CSP also induces an increase in the secretion levels of IL-6, TNF-α, and NO [161].

6.11.5. Anti-Ulcer Effect

In recent years, despite the efficacy of antiplatelet drugs such as aspirin and clopidogrel in managing arterial circulation disorders caused by excessive platelet aggregation, it is crucial to consider potential gastrointestinal complications like gastric bleeding and ulceration when administering these medications.
CSR has also demonstrated positive outcomes in the restoration and optimization of digestive functionality. The following examples are provided. The administration of CSP (100 mg/kg, 200 mg/kg, 400 mg/kg) effectively inhibits the development of water immersion restraint stress-induced gastric ulcers and pyloric ligation-induced gastric ulcer index in Wister rats. It also enhances the microcirculation of the gastric mucosa and improves its defensive capabilities, thereby exerting an anti-ulcer effect [162]. Additionally, CSR can stimulate the synthesis and release of endogenous prostaglandin E2 (PGE2) and epidermal growth factor (EGF), enhance mucosal blood defense and repair functions of gastric mucosa, suppress the inflammatory mediator platelet-activating factor (PAF), mitigate its damage to mucosa, and restore the balance and defense factors for achieving an anti-gastric ulcer effect [163].

6.11.6. Anti-Depressant Effect

The therapeutic potential of CSF has garnered significant attention in research studies. The administration of CSF at doses of 0.2 g/kg, 0.1 g/kg, and 0.05 g/kg has mitigated perimenopausal depression in female SD rats by modulating the hypothalamic-pituitary-gonadal axis through an increase in E2 levels [164]. Not singly but in pairs, CSF (400 mg/kg, 200 mg/kg, 100 mg/kg) also effectively demonstrates significant therapeutic efficacy in perimenopausal depression KM female mice, ameliorating the pathological alterations in the uterus, thymus, spleen, and hypothalamus [165].

6.11.7. Anti-Epileptic

The maximum electroconvulsive seizure (MES) model is widely regarded as a robust experimental model for grand mal epilepsy. The clinical efficacy of drugs with potent anti-MES effects extends to grand mal seizures. Based on this, CSR aqueous extract (1 g/mL), which exhibits a potent anti-MES effect in KM mice, holds promising potential for the treatment of grand mal epilepsy [99].

6.11.8. Anti-Bacterial

For good measure, the polyphenolic compounds and polymeric procyanidins present in CSR exhibit antibacterial properties. Cynomoriitannin (MIC = 64 μg/mL) demonstrates higher efficacy against methicillin-resistant staphylococcus aureus (MRSA) than other compounds separated from CSR [41] (Table S11, Supplementary Materials).

7. Toxicity

A growing awareness of food safety has led to a growing focus on CSR, which is a homology between medicine and food. The evaluation of a new potential drug’s safety is crucial not only in the concept of fitness and healthcare but also in its research and development. Several studies were conducted to evaluate the safety of CSR, including the contents of heavy metal ions detection and toxicity studies in vivo.

7.1. Heavy Metal Ions Detection

The levels of Cu, Pb, Cd, Cr, As, and Hg in CSR have been determined by microwave digestion and high-resolution continuous light source atomic absorption spectrometry [166]. The results indicated that the concentrations of these metals in CSR were far below the limitations of both the Green Industry Standard for Importing Medicinal Plants and Preparations as well as the national food safety standard named Maximum Levels of Contaminants in Foods (GB2762–2012).

7.2. Toxicity Studies In Vivo

Currently, CSR aqueous extract has been confirmed to have no obvious toxicity by experiments on acute toxicity tests, teratogenicity tests, and subchronic toxicity tests.
In acute toxicity experiments, the oral LD50 of CSR aqueous extract exceeded 21.5 g/kg in all cases [167]. The results of another study indicated that the maximum tolerable dose of CSR in KM mice is greater than 15 g/kg [168], also providing evidence of CSR aqueous extract nonobvious toxicity.
Salmonella typhimurium reverse mutation test, bone marrow polychromatic red blood cell micronucleus test, and sperm aberration test in KM mice were adopted to further investigate the genetic toxicity of CSR aqueous extract. One of the studies indicated that CSR aqueous extract (7.5 g/kg, 3.75 g/kg, and 1.875 g/kg) could not induce tested strains (TA97, TA98, TA100, TA102) to form colonies, as well as did not cause any mutagenic effects against the somatic cells and germ cells [169]. The results of the experiment are proved by another study conducted with CSR aqueous extract (2.25, 4.50, 9.00 g/kg), with the difference being the type of experimental strains (TA97, TA98, TA100, TA102, and TA1535) [167].
As the third stage of food safety toxicological evaluation, a subchronic toxicity test was conducted for a ninety-day feeding trial. No significant toxicological findings were detected in hematological parameters or clinical and pathological examinations when feeding various concentrations of CSR aqueous extract (1.04 g/kg, 2.08 g/kg, 4.16 g/kg) to SD rats [168]. Three Doses of CSR aqueous extract (2.83 g/kg, 5.66 g/kg, 8.49 g/kg) were fed to Wistar rats in the same year’s research. Fu. Et [170] found that the medium (5.66 g/kg) and high (8.49 g/kg) dose groups exhibited significantly increased plasma prothrombin time (PT), as well as testicular organ coefficient and epididymal organ coefficient. The maximum no-observed-adverse-effect level (NOAEL) was determined to be 2.83 g/kg, while the minimum lowest-observed-adverse-effect level (LOAEL) was identified at 5.66 g/kg in this subchronic transoral toxicity study.
However, according to clinical reports, a patient was diagnosed with acute renal function injury after taking a single Chinese medicine CSR 100–150 g aqueous extract for about 0.5 h, experiencing nausea and vomiting 4–6 times, non-jet like, with all vomit being gastric contents, without abdominal pain or diarrhea, headache, or fever. Therefore, it is still essential to exercise caution and avoid an overdose of CSR [167].
Based on the current situation, most studies about the toxicity of CSR focus on its aqueous extract, and few on other extracts and extract components. In order to build a more comprehensive toxicity evaluation, subsequent studies are required to focus on CSR extracts from other solvents. Furthermore, further exploration of toxic compounds in CSR is also necessary. These will provide a more reliable scientific basis for the safe use of CSR.

8. Conclusions

In recent years, due to China’s aging population and growing demand for healthcare, CSR has emerged as a highly valuable Chinese herbal medicine. It is currently being investigated for its medicinal properties. A few studies have highlighted the beneficial effects of CSR on overall health. This has led to its incorporation into various compound preparations and health supplements, expanding its potential applications [171].
This study summarizes various studies on Cynomorium songaricum Rupr. (CSR) from various aspects such as botany, ethnic pharmacology, phytochemistry, modern pharmacology, and toxicology. Compared with previous reviews describing the effects of CSR, the data on phytochemistry and pharmacology in this study are complete and more comprehensive, which helps to provide a data reference for professionals studying CSR.
Traditional Chinese medicine CSR remains an outstanding kidney yang and tonifying remedy. Additionally, it nourishes the essence and blood, as well as moistening the intestines and bowel movements. Consequently, several traditional CSR prescriptions have been included in the Chinese Pharmacopoeia as modern clinical medications. Various active compounds such as flavonoids, terpenoids, and polysaccharides may be the molecular basis for CSR pharmacological activity. A portion of the 98 compounds isolated from CSR have pharmacological properties, including anti-tumor, antioxidant, neuroprotective, antiviral, and anti-diabetic properties, etc. However, most studies involving CSR mainly focus on simple validation of its effectiveness in extract administration. In vitro studies rarely involve in vivo mechanisms and there is a lack of modern pharmacological mechanism research on traditional Chinese medicine compound formulations.
Looking back at the entire article, there are also some shortcomings in this study. The literature collection work is up to June 2023. Afterwards, more recently published CSR-related studies may not be included. Although CSR has become a well-known health medication in China, its popularity internationally is still insufficient. This may be related to its limited distribution in other countries. Therefore, it is inevitable that foreign research cited is relatively scarce. We hope that this study can attract more people to be interested in and involved in the study of CSR. Furthermore, we look forward to the future where traditional Chinese medicine of this kind will be included in foreign pharmacopoeias. Furthermore, in phytochemistry, there is a lack of research on the pharmacological activities of some compounds isolated from CSR, so their IC50 values were not included in this study.
In a nutshell, the future direction of CSR should focus on further research into the pharmacology and toxicity of compounds. Further exploration of the pharmacological mechanisms underlying CSR needs to be conducted to address the current lack of research data, as well as the development of functional health products.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29050941/s1. Table S1. Cynomorium songaricum anti-tumor effects. Table S2. Cynomorium songaricum anti-oxidation function. Table S3. Cynomorium songaricum anti-aging effects. Table S4. Cynomorium songaricum anti-fatigue and anti-hypoxia activities. Table S5. Cynomorium songaricum effects on nervous system. Table S6. Cynomorium songaricum effects on reproductive system. Table S7. Cynomorium songaricum anti-virus. Table S8. Cynomorium songaricum anti-diabetic properties. Table S9. Cynomorium songaricum anti-osteoporosis effect. Table S10. Cynomorium songaricum liver protection. Table S11. Cynomorium songaricum other pharmacological effects.

Author Contributions

J.Z., C.B. and Y.Z. conceptualization and original draft preparation. X.C., L.H., B.M. and M.T. were responsible for collecting the available materials. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by the Inner Mongolia Autonomous Region Scientific Research Project. Project ID NJZY21613.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

CSRCynomorium songaricum Rupr.HPLC-MSHigh-performance liquid chromatography–mass spectrometry.
VUVulnerable TLCThin layer chromatography
IUCNInternational Union for Conservation of Nature HR-MSHigh-resolution mass spectrometry
CITESConvention on International Trade in Endangered Species of Wild Fauna and Flora GC-MSGas chromatography–mass spectrometry
UVUltraviolet spectrophotometryFAB-MSFast atom bombardment mass spectrometry
IRInfrared spectroscopyHMQCHeteronuclear multiple quantum coherence
ESI-MSElectrospray ionization mass spectrometryHMBCHeteronuclear multiple bond connectivity
13C NMRCarbon-13 nuclear magnetic resonance spectrometryCDCircular dichroism
1H NMRHydrogen-1 nuclear magnetic resonance spectrometry1H–1HCOSYHomonuclear Correlation Spectroscopy
HPLCHigh-pressure liquid chromatographyCSPCSR polysaccharides
CSFCSR flavonoidsABTS2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
TERTTelomerase reverse transcriptase XOXanthine oxidase
BNIP3Bcl-2/adenovirus E1B 19 kDa-interacting protein 3SODSuperoxide dismutase
BNIP3LBcl-2/adenovirus E1B 19 kDa protein-interacting protein 3-likeKM miceKunming mice
DPPH2,2-Diphenyl-1-picrylhydrazyl cAMPCyclic adenosine monophosphate
cGMPCyclic guanosine monophosphateBDNFBrain-Derived Neurotrophic Factor
MAOmonoamine oxidaseTrkBTyrosine Kinase receptor B
ROSReactive oxygen speciesACHAcetylcholine
HPX/XO Hypoxanthine/Xanthine oxidaseNADPHNicotinamide adenine dinucleotide phosphate
XDH/XOXanthine dehydrogenaseNLRP3NOD-like receptor thermal protein domain associated protein 3
Aβ25–35Amyloidβ-Protein 25–35AMPAAmino-3-hydroxy-5-methy1-4-isoxazole propionic acid
MAPKMitogen-activated protein kinasesBPHBenign prostatic hyperplasia
Drp1Dynamin-related protein 1PCNAProliferating Cell Nuclear Antigen
Fis1Mitochondrial Fission 1 ProteinARAndrogen Receptor
ADAlzheimer’s diseaseErαEstrogen receptor α
OPA1Optic Atrophy 1ErβEstrogen receptor β
MFN1Mitofusin 1SRD5A 1/23-oxo-5-alpha-steroid 4-dehydrogenase 1/2
SD ratSprague-Dawley ratGSHGlutathione
GAP-43Growth-Associated Protein 43MDAMalondialdehyde
p-CREBPhosphorylation-cAMP response element-binding proteinFSHFollicle-stimulating Hormone
PSD-95Postsynaptic density protein-95ICSHInterstitial cell-stimulating hormone
p-ErkPhosphor-extracellular regulated protein kinasesLHLuteinizing hormone
LTPLong-term PotentialGDNFGlial Cell Line-derived Neurotrophic Factor
ICRInstitute of Cancer ResearchMTTMethyl thiazolyl tetrazolium
CREBcAMP response element-binding proteinHIVHuman immunodeficiency virus
HCVHepatitis C virusp-GSK3βphosphor-glycogen synthase kinase-3β
CSPACSR water-soluble polysaccharideBcl-2B-cell lymphoma-2
STZStreptozotocinALPAlkaline phosphatase
AKTAmerican karate taeOPGOsteoclastogenesis inhibitory factor
eNOSendothelial nitric oxide synthaseRANKLReceptor Activator for Nuclear Factor-κ B Ligand
TNF-αTumor necrosis factor αRANKReceptor Activator for Nuclear Factor-κ B
PI3KPhosphatidylinositide 3-kinasesTRAPTartrate-resistant acid phosphatase
p-PI3Kphospho-phosphatidylinositide 3-kinasesDPDDihydropyrimidine dehydrogenase
p-AKTphospho-american karate taeTRAF6TNF receptor-associated factor 6
GSK3βGlycogen synthase kinase-3βNF-κBNuclear Factor-κB
GOTGlutamic oxalate transaminaseMCVMean corpuscular volume
GPTGlutamic pyruvate transaminaseRDWRed blood cell distribution width
NOAELNo-observed-adverse-effect levelTGF-β1Transforming Growth Factor β1
WBCWhite blood cellIL-1Interleukin 1
HCTHematocritASTAspartate aminotransferase
RBCRed blood cellALTAlanine aminotransferase
LDHLactate dehydrogenaseIFN-γInterferon-γ
LNLamininCTXCyclophosphamide
GSH-PxGlutathione peroxidaseIL-6Interleukin-6
NOSNitric oxide synthaseNONitric oxide
AMPKAdenosine phosphate-activated protein kinase PGE2Prostaglandin E2
PGC1Peroxisome proliferator-activated receptor γ coactivator-1EGFEpidermal growth factor
BUNBlood urea nitrogenPAFPlatelet-activating factor
CrCreatinineMESMaximum electroconvulsive seizure
MRSAMethicillin-resistant staphylococcus aureusLOAELLowest-observed-adverse-effect level

References

  1. Han, D.; Meng, H.; Zhang, Y. Research and development and utilization of ‘Desert Ginseng‘ Cynomorium songaricum plant resources. Chin. Wild Plant Resour. 2003, 4, 42–46. [Google Scholar]
  2. Meng, J.; Ding, C.; Peng, S.; Liu, Y.; Yan, J.; Cui, P. Simultaneous determination of seven different components in Cynomorium songaricum Rupr. by QAMS. Acta Pharm. Sin. 2023, 58, 2763–2770. [Google Scholar]
  3. Ren, M.; Yang, G.; Du, L.; Liu, F.; Zhang, D.; Shen, Q.; Guan, X.; Zhang, Y. Research advances in medicinal plants of Cynomorium songaricum. J. Biol. 2018, 35, 95–98. [Google Scholar]
  4. Ma, F.-P.; Yu, L.; Yang, Y.; Li, D.-X.; Shen, C.-Y.; Zhao, X.-S.; Luo, Q. Glycoside constituents with various antioxidant effects from fresh Cynomorium songaricum. J. Asian Nat. Prod. Res. 2021, 24, 784–793. [Google Scholar] [CrossRef]
  5. Cui, Z.; Guo, Z.; Miao, J.; Wang, Z.; Li, Q.; Chai, X.; Li, M. The genus Cynomorium in China: An ethnopharmacological and phytochemical review. J. Ethnopharmacol. 2013, 147, 1–15. [Google Scholar] [CrossRef]
  6. Zhang, W.; Zheng, N.; Rui, Y.; Fan, Q.; Duan, Y. Extraction technology and in vitro antioxidant activity of polysaccharide from wild of Cynomorium songaricum Rupr in Ningxia. Sci. Technol. Food Ind. 2014, 35, 279–284. [Google Scholar]
  7. Tohuti, R.; Kasimu, G.; Zhang, Q.; Rehman, A. Effect of different extraction parts from the Cynomorium songarium Rupr. on Caco-2 and study of the chemical constituents. J. Xinjiang Med. Univ. 2011, 34, 362–365. [Google Scholar]
  8. Ma, L.; Chen, G. The Differences of the Active Components from the Different Segments of the Succulent Stem of Cynomorium Songaricum Rupr. Lishizhen Med. Mater. Medica Res. 2008, 19, 2913–2914. [Google Scholar]
  9. Zhang, S.; Wang, Y.; Liu, L.; Yu, J.; Hu, J. Studies on Chemical Constituents of Herba Cynomorii. Chin. Pharm. J. 2007, 42, 975–977. [Google Scholar]
  10. Ma, C.M.; Nakamura, N.; Hattori, M.; Cai, S. Isolation of malonyl oleanolic acid hemiester as anti-HIV protease substance from the stems of Cynomorium songaricum. Chin. Pharm. J. 2002, 37, 18–20. [Google Scholar]
  11. Qu, S.H.; Wu, H.P.; Hu, S.X. Study on chemical constituents of herba Cynomorii. J. Xinjiang Med. Univ. 1991, 14, 207. [Google Scholar]
  12. Xu, X.; Zhang, C.; Li, C. Chemical components of Cynomorium songaricum Rupr. China J. Chin. Mater. Medica 1996, 21, 676–677. [Google Scholar]
  13. Wang, X.; Li, H.; Liu, M.; Jiao, H. Chemical constituents from Cynomorium songaricum Rupr. Chin. Tradit. Pat. Med. 2015, 37, 1737–1739. [Google Scholar]
  14. Li, M.; Abulizi, R.; Yang, J.; Hu, J. Immune function of different polar extracts from Cynomorium songaricum Rupr. in mice. J. Xinjiang Med. Univ. 2021, 44, 1379–1384. [Google Scholar]
  15. Sdiri, M.; Li, X.; Du, W.W.; El-Bok, S.; Xie, Y.Z.; Ben-Attia, M.; Yang, B.B. Anticancer Activity of Cynomorium coccineum. Cancers 2018, 10, 354. [Google Scholar] [CrossRef] [PubMed]
  16. Ma, C.M.; Nakamura, N.; Miyashiro, H.; Hattori, M.; Shimotohno, K. Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease. Chem. Pharm. Bull. 1999, 47, 141–145. [Google Scholar] [CrossRef]
  17. Tian, X.; Wang, M.; Zhang, T.; Ou, Q.; Wei, X.; Bai, D.; Yang, J. Experimental study of Cynomorium songaricum on the expression of NO, NOS, bcl-2 and bax gene in neurons of aging mice. Chin. J. Gerontol. 2005, 25, 446–447. [Google Scholar]
  18. Jia, H.; Ge, B.; Di, D.-L. Comparative study on anti-stress effect of different extracts from Cynomorium songaricum. Chin. J. Hosp. Pharm. 2009, 29, 1977–1980. [Google Scholar]
  19. Chen, J.; Lu, S. Flora of China; Science Press: Beijing, China, 2000; Volume 53, pp. 152–154. [Google Scholar]
  20. Mao, X.; Gu, Z.; Lv, X.; Qi, M.; Ge, B. Research Progress on Resource Chemistry, Pharmacological Effects and Development of Cynomorium cynomorium. Chin. Wild Plant Resour. 2022, 41, 50–54. [Google Scholar]
  21. Chen, Y.; Han, D.H.; Gao, H.; Luo, G.H.; Wang, J. Distribution and Utilization on Germplasm Resources of Host Plants of Cynomorium songaricum. Chin. Wild Plant Resour. 2013, 32, 45–47. [Google Scholar]
  22. Yuan, Y.; Yu, F.; Wang, X.; Song, C. Wild Cynomorium songaricum artificial domestication cultivation technology. Mod. Agric. 2011, 10, 054. [Google Scholar] [CrossRef]
  23. Chen, J.; Chen, X. The similarities and differences of parasitic plants Cynomorium songaricum and Cistanche breeding methods. Bull. Biol. 2016, 51, 11–13. [Google Scholar]
  24. Yang, H.; Gu, Z.; Guo, Y.; Mao, X.; Qi, M.; Ge, B. Research Progress in the Development and Application of Cynomorium songaricum Related Preparations and Health Products. Chin. Wild Plant Resour. 2023, 42, 83–88. [Google Scholar]
  25. Gao, Y. The development and utilization prospect of parasitic plant Cynomorium songaricum. J. Inn. Mong. For. Coll. 1996, 18, 45–49. [Google Scholar]
  26. Li, R.; Meng, Y.; Niuniu, G. The current clinical application status of Hu Qian Wan. Clin. J. Chin. Med. 2017, 9, 137–139. [Google Scholar]
  27. Cai, Z.; Lv, L. Guilu Bushen Pills in the treatment of 86 cases of impotence. Clin. J. Med. Off. 2004, 03, 122. [Google Scholar]
  28. Wang, W. Pharmacological study of Suoyang Gujing Pills. Sci. Technol. Innov. 2014, 05, 45. [Google Scholar]
  29. Wu, S. Curative Effects of Nephritis in Favor of Pills Treatment of Chronic Renal Failure. Guide China Med. 2011, 9, 188–189. [Google Scholar]
  30. Wu, X.; Qu, M.; Song, H.; Guan, Z.; Zhang, T. Improving Effect of Dabuyin Pill on Renal Function in DN Mice. Acta Chin. Med. Pharmacol. 2022, 50, 39–43. [Google Scholar]
  31. Pang, B.; Zhao, H. Clinical study on Ziyin Xusidan navel sticking in the treatment of male infertility. Mod. Chin. Med. 2004, 02, 34. [Google Scholar]
  32. Huifeng, W. Exploration of the effect of traditional Chinese medicine combined with locking steel plate treatment on comminuted intertrochanteric fractures in the elderly. Med. Forum 2016, 20, 1961–1962. [Google Scholar]
  33. Luo, X. Clinical efficacy of Shenlu Jianbu Pill in treating ischemic necrosis of the femoral head. J. Contemp. Clin. Med. 2022, 35, 101–102. [Google Scholar]
  34. Chaokai, C.; Guofen, L. 17 cases of femoral neck fracture were treated with modified Jianbu-Huqian pill combined with V-shaped intramedullary nail. J. Emerg. Tradit. Chin. Med. 2002, 05, 376. [Google Scholar]
  35. Peng, W.; Huang, J. Effect of modified lycium barbarum pill on cognitive function in patients with Alzheimer’s disease. Chin. Med. Mod. Distance Educ. China 2013, 11, 20–21. [Google Scholar]
  36. Tan, L.; Tang, M.; Gao, H.; Wang, W.; Ouyang, H.; Feng, X. A randomized double-blind positive-controlled clinical trial of Guilingji for treating mild-to-moderate elderly cognitive impairment with kidney deficiency and marrow reduction syndrome. Mod. J. Integr. Tradit. Chin. West. Med. 2022, 31, 3392–3397. [Google Scholar]
  37. Xue, K. Clinical Study on Modified Dabuyin Pill in the Treatment of Hyperthyroidism Complicated with Type 2 Diabetes. China Health Ind. 2012, 9, 174. [Google Scholar]
  38. Zhang, Z.; Yan, X.; Zhang, Y. Clinical Study on the Treatment of Perimenopausal Syndrome of Yin Deficiency Type with Modified Dabuyin Pill. J. Zhejiang Chin. Med. Univ. 2022, 46, 1363–1366. [Google Scholar]
  39. Zhang, X.; Chen, Y.; Cui, J.; Cheng, W. Extraction of Proanthocyanidins from Cynomorium songaricum Rupr. and Its Antioxidant and Antiglycation Activities. Nat. Prod. Res. Dev. 2018, 30, 2039–2048. [Google Scholar]
  40. Guo, Y.; Zhao, J.; Luan, N.; Zhang, J.; Li, D. Antioxidant Function of Flavonoids from Cynomorium songaricum Rupr. J. Anhui Agric. Sci. 2011, 39, 19763–19764. [Google Scholar]
  41. Jin, S.; Eerdunbayaer; Doi, A.; Kuroda, T.; Zhang, G.; Hatano, T.; Chen, G. Polyphenolic constituents of Cynomorium songaricum Rupr. and antibacterial effect of polymeric proanthocyanidin on methicillin-resistant Staphylococcus aureus. J. Agric. Food Chem. 2012, 60, 7297–7305. [Google Scholar] [CrossRef]
  42. Jiang, Z.H.; Tanaka, T.; Sakamoto, M.; Jiang, T.; Kouno, I. Studies on a medicinal parasitic plant: Lignans from the stems of Cynomorium songaricum. Chem. Pharm. Bull. 2001, 49, 1036–1038. [Google Scholar] [CrossRef]
  43. Tao, J.; Tu, P.; Xu, W.; Chen, D. Studies on Chemical Constituents and Pharmacological Effects of the Stem of Cynomorium songaricum Rupr. China J. Chin. Mater. Medica 1999, 24, 36–38. [Google Scholar]
  44. Wang, X.M.; Zhang, Q.; Kasimu, R.; Wang, X.L.; Wang, X.Q. Chemical constituents in whole plant of Cynomorium songaricum. Chin. Tradit. Herb. Drugs 2011, 42, 458–460. [Google Scholar]
  45. Meng, H.-C.; Wang, S.; Li, Y.; Kuang, Y.-Y.; Ma, C.-M. Chemical constituents and pharmacologic actions of Cynomorium plants. Chin. J. Nat. Med. 2013, 11, 321–329. [Google Scholar] [CrossRef]
  46. Zhang, Q.; Kasimu, R.; Wang, X.M.; Wang, X.L.; Wang, X.Q. Studies on the chemical constituents of flavonids in the inflorescences of Cynomorium songaricum Rupr. J. Xinjiang Med. Univ. 2007, 30, 466–468. [Google Scholar]
  47. Ma, C.M.; Wei, Y.; Wang, Z.G.; Hattori, M. Triterpenes from Cynomorium songaricium--analysis of HCV protease inhibitory activity, quantification, and content change under the influence of heating. J. Nat. Med. 2009, 63, 9–14. [Google Scholar] [CrossRef]
  48. Xie, S.; Li, G.; Wang, H.; Huang, J.; Kasimu, R.; Tan, Y.; Zhang, K.; Wang, J. Study on Chemical Constituents in Cynomorium songaricum. China Pharm. 2012, 15, 911–914. [Google Scholar]
  49. Zhang, L.; Pei, D.; Huang, Y.-R.; Wei, J.-T.; Di, D.-L.; Wang, L.-X. Chemical Constituents from Cynomorium songaricum. J. Chin. Med. Mater. 2016, 39, 74–77. [Google Scholar]
  50. Ma, C.M.; Jia, S.S.; Sun, T.; Zhang, Y.W. Triterpenes and steroidal compounds from Cynomorium songaricum. Acta Pharm. 1993, 28, 152–155. [Google Scholar]
  51. Zhou, Y.B.; Ye, R.R.; Lu, X.F.; Lin, P.C.; Yang, S.B.; Yue, P.P.; Zhang, C.X.; Peng, M. GC-MS analysis of liposoluble constituents from the stems of Cynomorium songaricum. J. Pharm. Biomed. Anal. 2009, 49, 1097–1100. [Google Scholar] [CrossRef]
  52. Zhang, S.-J.; Zhang, S.-Y.; Hu, J.-P. Studies on polysaccharide of Cynomorium songaricum Rupr. China J. Chin. Mater. Medica 2001, 26, 409–411. [Google Scholar]
  53. Wang, J.; Zhang, J.; Zhao, B.; Wu, Y.; Wang, C.; Wang, Y. Structural features and hypoglycaemic effects of Cynomorium songaricum polysaccharides on STZ-induced rats. Food Chem. 2010, 120, 443–451. [Google Scholar] [CrossRef]
  54. Shi, G.; Jiang, W.; Cai, L.; Sui, G. Molecular characteristics and antitumor capacity of Glycan extracted from Cynomorium songaricum. Int. J. Biol. Macromol. 2011, 48, 788–792. [Google Scholar] [CrossRef]
  55. Zhang, C.Z.; Xu, X.Z.; Li, C.; Zhang, C.Z.; Lanzhou, M.C. Fructosides from Cynomorium songaricum. Phytochemistry 1996, 41, 975–976. [Google Scholar] [CrossRef]
  56. Shin, M.; Munekazu, I. Study on the Constituents of Useful Plant: IV. Constituents of the calyx of diosryrose kaki, and carbon-13 nuclear magnetic resonance spectrs of flavonol glycosides. Chem. Pharm. Bull. 1978, 26, 1936–1941. [Google Scholar]
  57. Xie, S.; Li, G.; Zhang, K.; Wang, H.; Tan, Y.; Wang, J. Isolation and identification of chemical constituents from Cynomorium songaricum. J. Shenyang Pharm. Univ. 2012, 29, 525–528. [Google Scholar]
  58. Wang, X.; Tao, R.; Yang, J.; Miao, L.; Wang, Y.; Munyangaju, J.E.; Wichai, N.; Wang, H.; Zhu, Y.; Liu, E.; et al. Compounds from Cynomorium songaricum with Estrogenic and Androgenic Activities Suppress the Oestrogen/Androgen-Induced BPH Process. Evid. Based Complement. Altern. Med. 2017, 2017, 6438013. [Google Scholar] [CrossRef] [PubMed]
  59. Qian, Z. Fundamental Studies of Chemical Constituents of Cynomorium songaricum RUPR; Xinjiang Medical University: Ürümqi, China, 2007. [Google Scholar]
  60. Yao, J.; Niu, S.; Da, W.Y.; Zeng, J.Y.; Wang, L.Z. Component analysis on alcoholic beverage brewed from Cynomorium sougaricam. J. Northwest Norm. Univ. 2001, 37, 73–75. [Google Scholar]
  61. Zhang, S.; Zhang, S. Studies on the Volatile Components of Herba Cynomorii. China J. Chin. Mater. Medica 1990, 15, 39–41. [Google Scholar]
  62. Xue, G.Q.; Liu, Q.; Ren, X.F.; Han, Y.Q. Determination of Fifteen Metal Elements in Cynomorium Songaricumi by Flame Atomic Absorption Spectrophotometry (FAAS). Spectrosc. Spectr. Anal. 2004, 24, 1461–1463. [Google Scholar]
  63. Li, Z.H.; Guo, J.X.; Cui, Z.H.; Xu, J.P.; Zhang, C.H.; Li, M.H. Phytochemical and Pharmacological Progress and Resource Conservation Review of Cynomorium songaricum Rupr. Mod. Chin. Med. 2014, 16, 861–869. [Google Scholar]
  64. Meng, H.C.; Ma, C.M. Flavan-3-ol-cysteine and acetylcysteine conjugates from edible reagents and the stems of Cynomorium songaricum as potent antioxidants. Food Chem. 2013, 141, 2691–2696. [Google Scholar] [CrossRef]
  65. Wang, S.; Gao, S.; Li, W. Study on the Extraction, Purification and Pharmacological Activity of Astragalus Polysaccharide. Spec. Wild Econ. Anim. Plant Res. 2021, 170, 1–8. [Google Scholar]
  66. Li, X.; Sdiri, M.; Peng, J.; Xie, Y.; Yang, B.B. Identification and characterization of chemical components in the bioactive fractions of Cynomorium coccineum that possess anticancer activity. Int. J. Biol. Sci. 2020, 16, 61–73. [Google Scholar] [CrossRef] [PubMed]
  67. Nishida, S.; Kikuichi, S.; Yoshioka, S.; Tsubaki, M.; Fujii, Y.; Matsuda, H.; Kubo, M.; Irimajiri, K. Induction of apoptosis in HL-60 cells treated with medicinal herbs. Am. J. Chin. Med. 2003, 31, 551–562. [Google Scholar] [CrossRef] [PubMed]
  68. Yang, F.; Zhao, P.-W.; Sun, P.; Ma, L.-J.; Zhao, P.-W. Effect of Cynomorium songaricum polysaccharide on telomere of lung cancer A549 cells. China J. Chin. Mater. Medica 2016, 41, 917–921. [Google Scholar]
  69. Vascellari, S.; Zucca, P.; Perra, D.; Serra, A.; Piras, A.; Rescigno, A. Antiproliferative and antiviral activity of methanolic extracts from Sardinian Maltese Mushroom (Cynomorium coccineum L.). Nat. Prod. Res. 2021, 35, 2967–2971. [Google Scholar] [CrossRef] [PubMed]
  70. Zhang, H.; Luo, G.; Hao, J.; Yang, S.; Cui, W.; Zhang, J. Optimization of Ultrasonic-Assisted Enzymatic Extraction of Polysaccharides from Cynomorium songaricum and Their Antitumor Activity. Food Sci. 2016, 37, 59–64. [Google Scholar]
  71. Rina, S.; Yu, D. Research on Antioxidant Activity of the Alcohol Extract from Different Parts of Cynomorium songaricum. J. Inn. Mong. Norm. Univ. 2016, 45, 384–391. [Google Scholar]
  72. Lu, Y.; Cheng, F.; Wang, X.; Zhong, X.; Wang, Q. Antioxidant Activities of Different Extracts of Cynomorium Songaricum and Their Protective Effects against Hypoxanthine/Xanthine Oxidase-Induced Cell Injury: A Comparative Study. J. Anhui Univ. Chin. Med. 2012, 31, 57–60. [Google Scholar]
  73. Lu, Y.; Wang, Q.; Melzig, M.F.; Jenett-Siems, K. Extracts of Cynomorium songaricum protect SK-N-SH human neuroblastoma cells against staurosporine-induced apoptosis potentially through their radical scavenging activity. Phytother. Res. 2009, 23, 257–261. [Google Scholar] [CrossRef]
  74. Wang, N.; Wei, J.; Pei, D.; Hu, Q.; Zhang, L.; Di, D.; Liu, Y. Evaluation of antioxidative activity for aqueous extract from Cynomorium songaricum Rupr. Food Sci. Technol. 2016, 41, 237–240. [Google Scholar]
  75. Seo, S.-J.; Han, M.-R.; Lee, Y.-S. Antioxidant and Xanthine Oxidase Inhibition Activities of Cynomorium songaricum Extracts. Prev. Nutr. Food Sci. 2011, 16, 307–312. [Google Scholar] [CrossRef]
  76. Zhang, X.; Zhang, F.; Luo, G. Aqueous two phase system based on C_4mim BF_4/MgSO_4 for isolation of total flavonoids from Cynomorium Songaricum and its antioxidation activity analysis. Sci. Technol. Food Ind. 2016, 37, 242–246. [Google Scholar]
  77. Duan, Y.; Ma, Y.; Chen, G. Comparation of Antioxidant Activity of Crude Polyphenol and Polysaccharide in Cynomorium songaricum. Mod. Chin. Med. 2012, 14, 43–46. [Google Scholar]
  78. Jin, S.-W.; Chen, G.-L.; Du, J.-J.-M.; Wang, L.-H.; Ren, X.; An, T.-Y. Antioxidant Properties and Principal Phenolic Compositions of Cynomorium Songaricum Rupr. Int. J. Food Prop. 2013, 17, 13–25. [Google Scholar] [CrossRef]
  79. Wang, G.; Huang, X.; Pei, D.; Duan, W.; Quan, K.; Li, X.; Di, D. DPPH-HPLC-DAD analysis combined HSCCC for screening and identification of radical scavengers in Cynomorium songaricum Rupr. New J. Chem. 2016, 40, 3885–3891. [Google Scholar] [CrossRef]
  80. Li, L.; Liu, Y.; Li, H.; Zhang, G.; Wang, X.; Di, D. Effect of Cynomorium songaricum Rupr. Extracts on Antioxidative System in Mice. Lishizhen Med. Mater. Medica Res. 2011, 22, 2093–2095. [Google Scholar]
  81. Liu, H.P.; Chang, R.F.; Wu, Y.S.; Lin, W.Y.; Tsai, F.J. The Yang-Tonifying Herbal Medicine Cynomorium songaricum Extends Lifespan and Delays Aging in Drosophila. Evid. Based Complement. Alternat. Med. 2012, 2012, 735481. [Google Scholar] [CrossRef]
  82. Hu, M.; Su, L.; Zhang, X.; Zhang, Y.; Li, L.; Lu, Y. Effects of Cynomorium extract on aging of Caenorhabditis elegans based on transcriptome sequencing. Mod. J. Integr. Tradit. Chin. West. Med. 2022, 31, 2488–2495. [Google Scholar]
  83. Ma, L.; Chen, G.; Nie, L.; Ai, M. Effect of Cynomorium songaricum polysaccharide on telomere length in blood and brain of D-galactose-induced senescence mice. China J. Chin. Mater. Medica 2009, 34, 1257–1260. [Google Scholar]
  84. Ma, L.; Chen, G.; Jia, H.; Xie, J. Anti-senescence effect of Cynomorium Songaricum polysaccharide on D-galactose-induced aging mice. Chin. J. Hosp. Pharm. 2009, 29, 1186–1189. [Google Scholar]
  85. Su, Y.; Liu, Y.-Q.; Wu, J.-J.; Zhang, Y.; Yan, C.-L.; Nie, L. Effect of Cynomorium Songaricum Rupr. chewable tablets on immunopathologic changes and free radical of spleen in aging rats. Chin. J. Gerontol. 2009, 29, 927–929. [Google Scholar]
  86. Su, Y.; Liu, Y.-Q.; Zhang, Y.; Yan, C.-L.; Wu, J.; Zheng, W. Effects of Cynomorium Polysaccharide Chewable Tablets on NO Metabolism and Immune Function of D-galactose-induced Aging Rats. Tradit. Chin. Drug Res. Clin. Pharmacol. 2008, 19, 458–461. [Google Scholar]
  87. Liu, Y.-Q.; Su, Y.; Wu, J.; Zhang, Y.; Wei, S.; Nie, L.; Yan, C.-L. Effects of Cynomorium songaricum extract on immune function and free radical metabolism in aging model mice. Chin. J. Cell. Mol. Immunol. 2009, 25, 55–57. [Google Scholar]
  88. Cao, J.; Han, R.; Luo, H.; Guo, J.; Zheng, L. Effects of different extracts of Cynomorium songaricum on neurons in hippocampal CA1 region of aging model mice induced by D-galactose. Lishizhen Med. Mater. Medica Res. 2017, 28, 1326–1328. [Google Scholar]
  89. Shang, L.; Li, J.; Shang, J. Anti-aging effect of Cynomorium songaricum polysaccharide. Chin. J. Gerontol. 2018, 38, 1458–1460. [Google Scholar]
  90. Li, L.; Zhang, T. Effect of Cynomorium songaricum water extract on energy metabolism of liver mitochondria in aging model mice. Chin. J. Gerontol. 2010, 30, 1713–1714. [Google Scholar]
  91. Wang, Z.; Guo, D.; Fu, Y.; Li, D. The effect of Cynomorium songaricum Rupr on endurance and antioxidative status of skeletal muscle in trained mice. J. Northwest Norm. Univ. 2006, 42, 100–102. [Google Scholar]
  92. Li, D.; Ma, W. Effects of Cynomorium songaricum decoction upon the metabolism of free radical and liver glycogen of liver tissue of exercise rats. Mod. Prev. Med. 2013, 40, 1478–1482. [Google Scholar]
  93. Guo, W.; Cao, J.; Zhou, H. Effect of Cynomorium songarium Rupr on Testosterone Content, Substance Metabolism and Anti-fatigue Capacity of Rats After Exercise Training. Nat. Prod. Res. Dev. 2014, 26, 27–32. [Google Scholar]
  94. Wan, L.; Wang, J.; Du, Y.; Sun, J.; Meng, W.; Lu, X.; Zhou, Y. Effect of ethanol extract of Cynomorium songaricum Rupr. on anti-fatigue ability in exercise mice. J. Gansu Agric. Univ. 2019, 54, 23–30. [Google Scholar]
  95. Rui, F.; Li, D. Effect of Cynomorium songaricum decoction on free radical metabolism and exercise ability of skeletal muscle in rats. J. Chifeng Univ. 2010, 26, 114–115. [Google Scholar]
  96. Yu, F.-R.; Liu, Y.; Cui, Y.-Z.; Chan, E.-Q.; Xie, M.-R.; McGuire, P.P.; Yu, F.-H. Effects of a Flavonoid Extract from Cynomorium songaricum on the Swimming Endurance of Rats. Am. J. Chin. Med. 2010, 38, 65–73. [Google Scholar] [CrossRef] [PubMed]
  97. Yu, F.; Feng, S.; Xie, M.; Lian, X. Anti-fatigue Effect of Cynomorium Songaricum Flavone on Old Rats. Chin. J. Rehabil. Theory Pract. 2008, 14, 1141–1142. [Google Scholar]
  98. Yu, F.; Feng, S.; Xie, M.; Lian, X. Effects of Cynomorium songaricum flavones on the exercise tolerance and antixidation in rats. Drugs Clin. 2009, 24, 52–54. [Google Scholar]
  99. Hu, Y.; Wang, Z.; Xiao, W. Studies on Anti-anoxia and Anti-epilepsy of Cynomorium songaricum. J. Shihezi Univ. 2005, 23, 302–303. [Google Scholar]
  100. Yuan, Y.; Zhao, G.; Guo, H. Effects of Cynomorium songaricum on anti-tiredness and anti-oxygen-deficiency and their influence on the content of hemoglobin. J. Tianshui Norm. Univ. 2001, 2, 49–50. [Google Scholar]
  101. Zhang, R.X.; Jia, Z.P.; Li, M.X.; Wang, J.; Yin, Q.; Luo, J.D.; Liu, H.Y. Effect of aqueous extract part III from Cynomorium songaricum Rupr. on the protein level and pathomorphology of cerebra and cardia in hypoxia mice. Med. J. Natl. Defending Forces Northwest China 2008, 29, 241–243. [Google Scholar]
  102. Lu, Y.; Wang, Q.; Melzig, M.F.; Jenett-Siems, K. Extracts of Cynomorium songaricum protect human neuroblastoma cells from beta-amyloid(25–35) and superoxide anion induced injury. Pharmazie 2009, 64, 609–612. [Google Scholar] [PubMed]
  103. Wang, F.; Liu, Q.; Wang, W.; Li, X.; Zhang, J. A polysaccharide isolated from Cynomorium songaricum Rupr. protects PC12 cells against H₂O₂-induced injury. Int. J. Biol. Macromol. 2016, 87, 222–228. [Google Scholar] [CrossRef] [PubMed]
  104. Cao, J.; Han, R.; Guo, J.; Zhang, Y. The effect of Cynomorium ethyl acetate extract containing serum on the Injured PC12 Cells Induced by Aβ25–35. Pharmacol. Clin. Chin. Mater. Medica 2018, 34, 88–91. [Google Scholar]
  105. Zheng, J.; Ma, S.; Yu, X.; Hu, J.; Liu, Y.; Tian, F.; Lu, Y. Estrogen-like Effect of Ethyl Acetate Extract of Cynomorium songaricum Rupr. Nat. Prod. Res. Dev. 2016, 28, 1687–1690. [Google Scholar]
  106. Cheng, D.; Su, L.; Wang, X.; Li, X.; Li, L.; Hu, M.; Lu, Y. Extract of Cynomorium songaricum ameliorates mitochondrial ultrastructure impairments and dysfunction in two different in vitro models of Alzheimer’s disease. BMC Complement. Med. Ther. 2021, 21, 1–14. [Google Scholar] [CrossRef]
  107. Li, X.; Cheng, D.; Li, L.; Su, L.; Lu, Y. Study on mechanism of action of Cynomorium on Alzheimer’s disease based on mitochondrial dynamics imbalance regulation. Drug Eval. Res. 2020, 43, 451–456. [Google Scholar]
  108. Li, X.; Chen, J.; Lu, Y. Regulatory Effect of Ethyl Acetate Extract of Cynomorium Songaricum on Intestinal Flora Disorder in Alzheimer’s Disease Mice. Acta Chin. Med. 2022, 37, 126–134. [Google Scholar]
  109. Tian, F.; Chang, H.; Zhou, J.; Lu, Y. Effects of ethyl acetate extract from Cynomorim songaricum Rupr. on learning and memory function and hippocampal neurons in ovariecto-mized rat model with Alzheimer’s disease. J. Beijing Univ. Tradit. Chin. Med. 2014, 37, 763–766. [Google Scholar]
  110. Ma, S.; Zheng, J.; Chang, H.; Tian, F.; Cheng, D.; Wang, X.; Lu, Y. Effect of Cynomorium songaricum Ethyl Acetate Extract on Cognitive Dysfunction Induced by Chronic Stress. Nat. Prod. Res. Dev. 2017, 29, 1302–1306. [Google Scholar]
  111. Ma, S.; Zheng, J.; Cheng, D.; Tian, F.; Chang, H.; She, G.; Lu, Y. Mechanisms of the Ethyl Acetate Extract of Cynomorium Songaricum on the MAPK/ERK1/2 Signal Pathway for the Improvements in Cognitive Dysfunction Induced by Chronic Stress. World J. Integr. Tradit. West. Med. 2017, 12, 1381–1385. [Google Scholar]
  112. Ma, S.; Chang, H.; Zheng, J.; Cheng, D.; She, G.; Wang, X.; Lu, Y. Effects of ECS in improving long-term potentiation and chronic stress cognitive dysfunction. China J. Tradit. Chin. Med. Pharm. 2017, 32, 4608–4610. [Google Scholar]
  113. Tian, F.Z.; Chang, H.S.; Liu, J.X.; Zheng, J.; Cheng, D.; Lu, Y. Cynomorium songaricum Extract Alleviates Memory Impairment through Increasing CREB/BDNF via Suppression of p38MAPK/ERK Pathway in Ovariectomized Rats. Evid. Based Complement. Alternat. Med. 2019, 2019, 1–10. [Google Scholar] [CrossRef]
  114. Yoo, D.Y.; Choi, J.H.; Kim, W.; Jung, H.Y.; Nam, S.M.; Kim, J.W.; Yoon, Y.S.; Yoo, K.-Y.; Won, M.-H.; Hwang, I.K. Cynomorium songaricum extract enhances novel object recognition, cell proliferation and neuroblast differentiation in the mice via improving hippocampal environment. BMC Complement. Altern. Med. 2014, 14, 1–8. [Google Scholar] [CrossRef]
  115. Wu, M.; Liu, L.; Hu, Y.; Liu, J. Effect of Cynomorium songaricum water extract on scopolamine-induced learning and memory impairment in mice. Xinjiang J. Tradit. Chin. Med. 2015, 33, 29–31. [Google Scholar]
  116. Lyu, X.; Gu, Z.; Qi, M.; Guo, Y.; Mao, X.; Ge, B. Effects of Cynomorium songaricum Flavonoids on Learning and Memory Ability of Alzheimer Disease Model Rats Based on BDNF/TrkB Signaling Pathway. Chin. J. Inf. Tradit. Chin. Med. 2023, 30, 94–100. [Google Scholar]
  117. Lyu, X.; Gu, Z.R.; Qi, M.; Guo, Y.; Mao, X.W.; Ge, B. Effects of Cynomorium Songaricum Flavonoids on the Expressions of NADPH Oxidase, ROS and NLRP3 in the Hippocampus of Alzheimer’s Disease Rats. Chin. J. Inf. Tradit. Chin. Med. 2023, 30, 82–87. [Google Scholar]
  118. Shih, Y.H.; Chein, Y.C.; Wang, J.Y.; Fu, Y.S. Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats. Neurosci. Lett. 2004, 362, 136–140. [Google Scholar] [CrossRef]
  119. Tian, F.; Chang, H.; Zhou, J.; Zheng, J.; Gao, Y.; Xu, H.; Lu, Y. Effect of Ethyl Acetate Extract of Songaricum Rupr on p38 and CREB Characteristics of Ovariectomized Rats. Chin. Pharm. J. 2015, 50, 868–871. [Google Scholar]
  120. Wang, X.; Zhu, J.; Yan, H.; Shi, M.; Zheng, Q.; Wang, Y.; Zhu, Y.; Miao, L.; Gao, X. Kaempferol inhibits benign prostatic hyperplasia by resisting the action of androgen. Eur. J. Pharmacol. 2021, 907, 174251. [Google Scholar] [CrossRef]
  121. Zhang, B.; Zhang, R.W.; Yin, X.Q.; Lao, Z.Z.; Zhang, Z.; Wu, Q.G.; Yu, L.W.; Lai, X.P.; Wan, Y.H.; Li, G. Inhibitory activities of some traditional Chinese herbs against testosterone 5alpha-reductase and effects of Cacumen platycladi on hair re-growth in testosterone-treated mice. J. Ethnopharmacol. 2016, 177, 1–9. [Google Scholar] [CrossRef]
  122. Tao, R.; Wang, F.; Miao, L.; Zhang, H.; Zhang, J.; Fan, G. Effect and its mechanism of Cynomorium songaricum Rupr inhibiting benign prostatic hyperplasia. Chin. J. Clin. Pharmacol. 2018, 34, 2847–2850. [Google Scholar]
  123. Tao, R.; Miao, L.; Yu, X.; Orgah, J.O.; Barnabas, O.; Chang, Y.; Liu, E.; Fan, G.; Gao, X. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-alpha-reductase. J. Ethnopharmacol. 2019, 235, 65–74. [Google Scholar] [CrossRef]
  124. Fu, X.; Li, H.; Lang, D.; Zhang, X. Experimental Study on Effect of Cynomorium Deeoet in Rats with Benign Prostatic Hyperplasis. Asia-Pac. Tradit. Med. 2013, 9, 20–22. [Google Scholar]
  125. Yun, X.; Wang, Z.; Zhou, W.; Liu, E.; Tao, R.; Miao, L.; Jiao, C.; Wang, X. Relaxed effect of Cynomorium songaricum Rupr and its active ingredients on detrusor muscle strip tension in rats. Chin. J. Clin. Pharmacol. 2017, 33, 1938–1941. [Google Scholar]
  126. Zhou, S.H.; Deng, Y.F.; Weng, Z.W.; Weng, H.W.; Liu, Z.D. Traditional Chinese Medicine as a Remedy for Male Infertility: A Review. World J. Mens. Health 2019, 37, 175–185. [Google Scholar] [CrossRef]
  127. Abdel-Magied, E.M.; Abdel-Rahman, H.A.; Harraz, F.M. The effect of aqueous extracts of Cynomorium coccineum and Withania somnifera on testicular development in immature Wistar rats. J. Ethnopharmacol. 2001, 75, 1–4. [Google Scholar] [CrossRef] [PubMed]
  128. Gu, J.; Li, Z.; Qi, Y.; Cao, Y. The effect of Cynomorium on the semen quality and sex hormone level in the oligospermia rat model. Contemp. Med. 2021, 27, 14–16. [Google Scholar]
  129. Cao, Y.-J.; Li, Z.-B.; Qi, Y.-J.; Liu, Y.; Gu, J.; Hu, F.-F.; Zhang, W.-d.; Hao, L.; Hou, J.-Q.; Han, C.-H. Cynomorium songaricum improves sperm count and motility and serum testosterone level and promotes proliferation of undifferentiated spermatogonia in oligoasthenospermia rats. Natl. J. Androl. 2016, 22, 1116–1121. [Google Scholar]
  130. Han, X.; Zhou, R.; Zheng, W.; Wang, X.; Mao, S.; Li, Z.; Hao, L.; Shi, Z.; Chen, B.; Zhang, Z.; et al. Cynomorium Songaricum may protect against spermatogenic damage caused by cyclophosphamide in SD rats. Rev. Romana Med. Lab. 2019, 27, 291–303. [Google Scholar] [CrossRef]
  131. Yang, W.M.; Kim, H.Y.; Park, S.Y.; Kim, H.M.; Chang, M.S.; Park, S.K. Cynomorium songaricum induces spermatogenesis with glial cell-derived neurotrophic factor (GDNF) enhancement in rat testes. J. Ethnopharmacol. 2010, 128, 693–696. [Google Scholar] [CrossRef] [PubMed]
  132. Lee, J.S.; Oh, H.A.; Kwon, J.Y.; Jeong, M.H.; Lee, J.S.; Kang, D.W.; Choi, D. The Effects of Cynomorium songaricum on the Reproductive Activity in Male Golden Hamsters. Dev. Reprod. 2013, 17, 37–43. [Google Scholar] [CrossRef]
  133. He, X.; Fang, J.; Guo, Q.; Wang, M.; Li, Y.; Meng, Y.; Huang, L. Advances in antiviral polysaccharides derived from edible and medicinal plants and mushrooms. Carbohydr. Polym. 2020, 229, 115548. [Google Scholar] [CrossRef] [PubMed]
  134. Tuvaanjav, S.; Shuqin, H.; Komata, M.; Ma, C.; Kanamoto, T.; Nakashima, H.; Yoshida, T. Isolation and antiviral activity of water-soluble Cynomorium songaricum Rupr. polysaccharides. J. Asian Nat. Prod. Res. 2016, 18, 159–171. [Google Scholar] [CrossRef]
  135. Gao, Q.H.; Fu, X.; Zhang, R.; Wang, Z.; Guo, M. Neuroprotective effects of plant polysaccharides: A review of the mechanisms. Int. J. Biol. Macromol. 2018, 106, 749–754. [Google Scholar] [CrossRef]
  136. Wang, Y.; Tian, Z. The effect of aerobic exercise and Cynomorium Songaricum Polysaccharide intervention for dilatation function of aorta in diabetes rats and involved mechanisms. J. Shaanxi Norm. Univ. 2017, 45, 117–124. [Google Scholar]
  137. Shi, Z.Q.; Wang, L.Y.; Zheng, J.Y.; Xin, G.Z.; Chen, L. Lipidomics characterization of the mechanism of Cynomorium songaricum polysaccharide on treating type 2 diabetes. J. Chromatogr. B Anal. Technol. Biomed Life Sci. 2021, 1176, 122737. [Google Scholar] [CrossRef] [PubMed]
  138. Ma, C.-M.; Sato, N.; Li, X.-Y.; Nakamura, N.; Hattori, M. Flavan-3-ol contents, anti-oxidative and α-glucosidase inhibitory activities of Cynomorium songaricum. Food Chem. 2010, 118, 116–119. [Google Scholar] [CrossRef]
  139. Yin, J.; Tezuka, Y.; Kouda, K.; Le Tran, Q.; Miyahara, T.; Chen, Y.J.; Kadota, S. Antiosteoporotic activity of the water extract of Dioscorea spongiosa. Biol. Pharm. Bull. 2004, 27, 583–586. [Google Scholar] [CrossRef]
  140. Hu, J.; Tan, R.; Yuan, Z.; Yang, P.; Zhang, C.; Zhang, B.; Shen, Y. Cynomorium songaricum polysaccharide promotes osteogenic differentiation of MC3T3⁃E1 cells by activating PI3K/Akt/GSK3β/β⁃catenin signaling pathway. J. Pract. Med. 2022, 38, 2774–2779. [Google Scholar]
  141. Xue, W.; Dai, N.; Feng, F.; Wang, F.; Luo, L.; Huang, J.; Cheng, Z. Cynomorium songaricum extract promotes osteoblast differentiation and inhibits lipopolysaccharide induced apoptosis of osteoblast. Biomed. Res. India 2017, 28, 6567–6570. [Google Scholar]
  142. Wu, H.; Zhang, L.; Feng, X. Effects of cynomorium-containing serum on proliferation, differentiation and mineralization of osteoblasts MC3T3-E1 cultured in vitro. Pharm. Clin. Chin. Mater. Medica 2019, 10, 23–26. [Google Scholar]
  143. Shi, P.; Zhu, W.; Li, X. Cynomorium Songaricum polysaccharide improves osteoporosis in ovariectomized rats. J. Third Mil. Med. Univ. 2015, 37, 2360–2363. [Google Scholar]
  144. Zhang, X.; Xu, L.; Xu, X.; Ma, X. The effect of Cynomorium songaricum Rupr. on osteoporosis in ovariectomized rats. Pharmacol. Clin. Chin. Mater. Medica 2017, 33, 101–104. [Google Scholar]
  145. Ma, X.; Liu, J.; Yang, L.; Zhang, B.; Dong, Y.; Zhao, Q. Cynomorium songaricum prevents bone resorption in ovariectomized rats through RANKL/RANK/TRAF6 mediated suppression of PI3K/AKT and NF-kappaB pathways. Life Sci. 2018, 209, 140–148. [Google Scholar] [CrossRef] [PubMed]
  146. Borkham-Kamphorst, E.; Weiskirchen, R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev. 2016, 28, 53–61. [Google Scholar] [CrossRef]
  147. Roskams, T. Different types of liver progenitor cells and their niches. J. Hepatol. 2006, 45, 1–4. [Google Scholar] [CrossRef]
  148. Li, R.; Wang, H.; Lin, Y.; Liu, Y.; Li, H.; Huang, X.; Tang, L.; He, H.; Cui, L.; Deng, F. Effects of Cynomorium songaricum Extract on Liver Fibrosis Model Rats and Its Mechanism Study. China Pharm. 2016, 27, 3903–3906. [Google Scholar]
  149. Li, H.; Huang, X.; Guo, L.; Li, R.; Li, C.; Chen, J.; Huang, D.; Lin, Y.; Wang, H.; Liu, Y.; et al. Effect of Cynomorium on the Blood Cell Type of Rats with Hepatic Fibrosis. J. Chengdu Med. Coll. 2017, 12, 21–23. [Google Scholar]
  150. Huang, X.; Guo, L.; Li, C.; Li, R.; Li, H.; Kong, D.; Hu, K.; Lin, Y.; Deng, F.; Wang, H.; et al. Antagonism Effect of Cynomorium on CCl4 induced Liver Fibrosis by Inhibiting the Expression of Inflammatory Cytokines in Mice. J. Chengdu Med. Coll. 2018, 13, 249–261. [Google Scholar]
  151. Li, S.; Zhang, K.; Li, G.; Wang, H.; Chen, Y.; Peng, H.; Wang, J. The preventive effect of Cynomorium Songaricum on carbon tetrachloride induced liver fibrosis in mice. J. Shihezi Univ. 2017, 35, 368–372. [Google Scholar]
  152. Chen, J.; Wong, H.S.; Leung, H.Y.; Leong, P.K.; Chan, W.M.; Chen, N.; Ko, K.M. An ursolic acid-enriched extract of Cynomorium songaricum protects against carbon tetrachloride hepatotoxicity and gentamicin nephrotoxicity in rats possibly through a mitochondrial pathway: A comparison with ursolic acid. J. Funct. Foods 2014, 7, 330–341. [Google Scholar] [CrossRef]
  153. Duan, X.; Qu, X.; Bai, L.; Zhao, H.; Shang, J. Protective effect of flavonoids from Cynomorium songaricum on oxidative damage induced by formaldehyde in rat hepatic stellate cells. Asia-Pac. Tradit. Med. 2019, 15, 26–28. [Google Scholar]
  154. Li, L.; Huang, M.; Guo, J.; Chen, Z. Effect of Cynomorium songaricum Flavone on Rat Liver Cells after Oxidation Injury. Biol. Chem. Eng. 2022, 8, 36–39. [Google Scholar]
  155. Li, L. Effect of Cynomorium songaricum polysaccharide on mice of gastric emptying and intestinal propulsion. J. North Pharm. 2013, 10, 43–44. [Google Scholar]
  156. Li, H. The Effect of Cynomorium songaricum on the Contractile Function of Isolated Rabbit Jejunum Smooth Muscle. J. Med. Inf. 2020, 33, 82–84. [Google Scholar]
  157. Chen, J.; Wong, H.S.; Leung, H.Y.; Leong, P.K.; Chan, W.M.; Ko, K.M. An ursolic acid-enriched Cynomorium songarium extract attenuates high fat diet-induced obesity in mice possibly through mitochondrial uncoupling. J. Funct. Foods 2014, 9, 211–224. [Google Scholar] [CrossRef]
  158. Chen, J.; Leong, P.K.; Leung, H.Y.; Chan, W.M.; Wong, H.S.; Ko, K.M. 48Biochemical mechanisms of the anti-obesity effect of a triterpenoid-enriched extract of Cynomorium songaricum in mice with high-fat-diet-induced obesity. Phytomedicine 2020, 73, 153038. [Google Scholar] [CrossRef]
  159. Liu, Q.; Song, S.; Guo, J.; Luo, S.; Zhang, J. Protective effect of polysaccharide from Cynomorium songaricum Rupr on oxidative damage of VERO cells induced by H2O2. Chin. Tradit. Pat. Med. 2014, 36, 2023–2028. [Google Scholar]
  160. Zhang, R.-X.; Jia, Z.-P.; Li, M.-X.; Wang, J.; Yin, Q.; Luo, J.-D.; Liu, H.-Y. Study on the effect of Part III from Cynomorium songaricum on immunosuppressive mice induced by cyclophosphamide. J. Chin. Med. Mater. 2008, 31, 407–409. [Google Scholar]
  161. Abliz, R.; Li, M.; Hu, J.-P. Effect of polysaccharide from Cynomorium songaricumon on the immunoregulatory effect of RAW264.7 macrophages cell. J. Food Saf. Qual. 2018, 9, 5694–5698. [Google Scholar]
  162. Yang, Y.; Ma, C.; Dong, P.; Lei, L.; Nie, Y.; Yu, X.; Ren, C.; Qian, Z. Effects of Cynomorium songaricum polysaccharide on acute gastric ulcer in model rats. Anhui Med. Pharm. J. 2011, 15, 1204–1206. [Google Scholar]
  163. Yang, Y.; Ma, C.; Lei, L.; Dong, P.; Li, J. Effects of Cynomorium Songaricum Polysaccharide on Experimental Gastric Ulcer in Rats by Acetic Acid. Chin. Arch. Tradit. Chin. Med. 2012, 30, 385–387. [Google Scholar]
  164. Miao, M.; Yan, X.; Guo, L.; Li, P. Effect of Cynomorium total flavone on depression model of perimenopausal rat. Saudi J. Biol. Sci. 2017, 24, 139–148. [Google Scholar] [CrossRef] [PubMed]
  165. Wang, T.; Miao, M.; Li, Y.; Li, M.; Zhang, Y.; Tian, S. Effect of cynomorium flavonoids on morphology of perimenopausal depression mice model. Saudi Pharm. J. 2016, 24, 322–328. [Google Scholar] [CrossRef]
  166. Hu, Y.; Ding, Y.; Gao, X.; Li, X.; Shao, S. Determination of Heavy Metal Elements in Cynomorium and Leek Seeds by High Resolution Continuum Source Atomic Absorption Spectrometry with Microwave Digestion. Anal. Test. Technol. Instrum. 2016, 22, 90–95. [Google Scholar]
  167. Nie, L.; Ma, L.; Ai, M. Modern research progress on medicinal properties and functions of Cynomorium songaricum. Chin. J. Ethnomedicine Ethnopharmacy 2009, 18, 17–18. [Google Scholar]
  168. Wei, F.; He, Q.; Wang, W.; Pei, D.; Zhang, B. Toxicity Assessment of Chinese Herbal Medicine Cynomorium songaricum Rupr. Evid. Based Complement. Alternat. Med. 2019, 2019, 9819643. [Google Scholar] [CrossRef] [PubMed]
  169. Qu, L.; Yin, X.; Fan, S.; Qian, Y. Genetic Toχicity of Cynomorium Songaricum Rupr. J. Med. Pest Control 2016, 32, 275–278. [Google Scholar]
  170. Fu, S.; Xu, S.; Pei, D.; Qu, W.; Qu, J.; Tian, J. Subchronic toxicity test of Cynomorium songaricum herb aqueous extract in rat. J. Hyg. Res. 2019, 48, 104–108. [Google Scholar]
  171. Wu, J. The function and efficacy of traditional Chinese medicine Cynomorium songaricum and its development and utilization. Lishizhen Med. Mater. Medica Res. 2015, 26, 2492–2494. [Google Scholar]
Figure 1. The overall appearance (http://www.iplant.cn/frps/, accessed on 12 May 2023.) (a); whole grass (b); inflorescence (c); and herbal medicinal preparation (d) of Cynomorium songaricum Rupr.
Figure 1. The overall appearance (http://www.iplant.cn/frps/, accessed on 12 May 2023.) (a); whole grass (b); inflorescence (c); and herbal medicinal preparation (d) of Cynomorium songaricum Rupr.
Molecules 29 00941 g001
Figure 2. Major producing areas in China of Cynomorium songaricum Rupr. Inner Mongolia (Red), Gansu (Blue), Xinjiang (Orange), Qinghai (Purple), and Ningxia (Yellow).
Figure 2. Major producing areas in China of Cynomorium songaricum Rupr. Inner Mongolia (Red), Gansu (Blue), Xinjiang (Orange), Qinghai (Purple), and Ningxia (Yellow).
Molecules 29 00941 g002
Figure 3. Life cycle of Cynomorium songaricum Rupr.
Figure 3. Life cycle of Cynomorium songaricum Rupr.
Molecules 29 00941 g003
Figure 4. Percentage of chemical composition categories isolated from Cynomorium songaricum Rupr.
Figure 4. Percentage of chemical composition categories isolated from Cynomorium songaricum Rupr.
Molecules 29 00941 g004
Figure 5. The structures of compounds 127 from Cynomorium songaricum Rupr.
Figure 5. The structures of compounds 127 from Cynomorium songaricum Rupr.
Molecules 29 00941 g005
Figure 6. The structures of compounds 2839 from Cynomorium songaricum Rupr.
Figure 6. The structures of compounds 2839 from Cynomorium songaricum Rupr.
Molecules 29 00941 g006
Figure 7. The structures of compounds 4049 from Cynomorium songaricum Rupr.
Figure 7. The structures of compounds 4049 from Cynomorium songaricum Rupr.
Molecules 29 00941 g007
Figure 8. The structures of compounds 5062 from Cynomorium songaricum Rupr.
Figure 8. The structures of compounds 5062 from Cynomorium songaricum Rupr.
Molecules 29 00941 g008
Figure 9. The structures of compounds 6379 from Cynomorium songaricum Rupr.
Figure 9. The structures of compounds 6379 from Cynomorium songaricum Rupr.
Molecules 29 00941 g009
Figure 10. The structures of compounds 8085 from Cynomorium songaricum Rupr.
Figure 10. The structures of compounds 8085 from Cynomorium songaricum Rupr.
Molecules 29 00941 g010
Figure 11. The structures of compounds 8698 from Cynomorium songaricum Rupr.
Figure 11. The structures of compounds 8698 from Cynomorium songaricum Rupr.
Molecules 29 00941 g011
Figure 12. The main pharmacological action of Cynomorium songaricum Rupr.
Figure 12. The main pharmacological action of Cynomorium songaricum Rupr.
Molecules 29 00941 g012
Figure 13. Other pharmacological action of Cynomorium songaricum Rupr.
Figure 13. Other pharmacological action of Cynomorium songaricum Rupr.
Molecules 29 00941 g013
Table 2. Flavonoids isolated from Cynomorium songaricum Rupr.
Table 2. Flavonoids isolated from Cynomorium songaricum Rupr.
No.CompoundParts of PlantExtract SolventIdentificationReferences
1PhloridzinStems70% acetoneHPLC, 1H NMR, 13C NMR[42]
2(−)-EpicatechinStemschloroformUV, MS, 1H NMR, 13C NMR[9]
3NaringeninStemschloroformTLC, UV, IR, 1H NMR, 13C NMR[9]
4(−)-CatechinStemsethyl acetateIR, ESI-MS, 1H NMR, 13C NMR[43]
5Luteolin-7-O-glucosideStemsethyl acetate part1H NMR, 13C NMR[16]
6Procyanidin B1Stemsaqueous1H NMR, 13C NMR[16]
7Procyanidin B6Stemsaqueous1H NMR, 13C NMR[16]
8Procyanidin B3Fresh stems70% acetoneHPLC, 1H NMR, 13C NMR[41]
9Catechin-(6′-8)-catechinFresh stems70% acetoneHPLC, 1H NMR, 13C NMR[41]
10Catechin-(6′-6)-catechinFresh stems70% acetoneHPLC, 1H NMR, 13C NMR[41]
11Epicatechin-(4β-8)-epicatechin-(4β-8)-catechinFresh stems70% acetoneHPLC, 1H NMR, 13C NMR[41]
12Epicatechin-(4β-6)-epicatechin-(4β-8)-catechinFresh stems70% acetoneHPLC, 1H NMR, 13C NMR[41]
13Arecatannin A1Fresh stems70% acetoneHPLC, 1H NMR, 13C NMR[41]
14Dehydrodiconiferyl alcohol-9-O-β-D-glu-copyranosideFresh stemsethyl acetate part1H NMR, 13C NMR[4]
153′,4′,5,7-tetrahydroxy-flavanone-2(S)-3′-O-β-D-glucopyranosideFresh stemsethyl acetate part1H NMR, 13C NMR[4]
16Luteolin-4′-O-β-glucopyranosideFresh stemsethyl acetate part1H NMR, 13C NMR[4]
17AstragalinFresh stemsethyl acetate part1H NMR, 13C NMR[4]
18Quercetin-3-O-rutinosideFresh stemsethyl acetate part1H NMR, 13C NMR[4]
19Naringenin-7-O-β-D-glucopyranosideFresh stemsethyl acetate part1H NMR, 13C NMR[4]
20Naringenin-5-O-β-D-glucopyranosideFresh stemsethyl acetate part1H NMR, 13C NMR[4]
21Naringenin-4′-O-β-pyranoglucoseWhole grassN-butanol part1H NMR, 13C NMR[44]
22Cyanidin 3-O-glucosideInflorescences95% alcohol1H NMR, 13C NMR[45]
23Cyanidin 3-O-rhamnosylglucosideInflorescences95% alcohol1H NMR, 13C NMR[45]
24(+)-CatechinInflorescences95% alcoholTLC, 1H NMR, 13C NMR[46]
25IsoquercetinInflorescences95% alcohol1H NMR, 13C NMR[46]
26RutinInflorescences95% alcohol1H NMR, 13C NMR[46]
27(−)-Epicatechin-3-O-gallateInflorescences95% alcoholTLC, 1H NMR, 13C NMR[46]
UV: Ultraviolet spectrophotometry; IR: Infrared spectroscopy; ESI-MS: Electrospray ionization mass spectrometry; 13C NMR: Carbon-13 nuclear magnetic resonance spectrometry; 1H NMR: Hydrogen-1 nuclear magnetic resonance spectrometry; HPLC: High-pressure liquid chromatography; TLC: Thin layer chromatography.
Table 3. Terpenoids isolated from Cynomorium songaricum Rupr.
Table 3. Terpenoids isolated from Cynomorium songaricum Rupr.
No.CompoundParts of PlantExtract SolventIdentificationReferences
28Malonyl ursolic acid hemiesterStemsdichloromethane1H NMR, 13C NMR[16]
29Ursolic acidStemsdichloromethane1H NMR, 13C NMR[16]
30Acetyl ursolic acidStemsdichloromethane1H NMR, 13C NMR[16]
31Oleanolic acidStemsdichloromethaneIR, 1H NMR, 13C NMR, HR-MS[16]
32Betulinic acidStemsdichloromethane1H NMR, 13C NMR[16]
33Malonyl oleanolic acid hemiesterStemsdichloromethaneHPLC, 1H NMR, 13C NMR[10]
34Glutaryl ursolic acid hemiesterStemsethyl acetateHPLC-MS[47]
35Oxalyl ursolic acid hemiesterStemsethyl acetateHPLC-MS[47]
36Succinyl ursolic acid hemiesterStemsethyl acetateHPLC-MS[47]
37Ursolic acid methyl esterStemsethyl acetateHPLC-MS[47]
383β,28-Dihydroxyoleana-11,13(18)-dieneStemsethyl acetate part1H NMR, 13C NMR[48]
39Maslinic acidStemsaqueousESI-MS, 1H NMR, 13C NMR[49]
IR: Infrared spectroscopy; 13C NMR: Carbon-13 nuclear magnetic resonance spectrometry; 1H NMR: Hydrogen-1 nuclear magnetic resonance spectrometry; HR-MS: High-resolution mass spectrometry; ESI-MS: Electrospray ionization mass spectrometry; HPLC: High-pressure liquid chromatography; HPLC-MS: High-performance liquid chromatography-mass spectrometry.
Table 4. Steroids isolated from Cynomorium songaricum Rupr.
Table 4. Steroids isolated from Cynomorium songaricum Rupr.
No.CompoundParts of PlantExtract SolventIdentificationReferences
405α-Stigmast-9(11)-en-3β-olStemsethyl acetateHR-MS, 1H NMR, 13C NMR[12]
415α-Stigmast-9(11)-en-3β-ol tetracosatrienoic acid esterStemsethyl acetateHR-MS, 1H NMR, 13C NMR[12]
42DaucosterolStemsethyl acetate partTLC[13]
43β-SitosterolStemsethyl acetate partTLC[13]
44β-Sitosteryl oleateStemsdichloromethaneHPLC, 1H NMR, 13C NMR[16]
45β-Sitosteryl glucosideStemsdichloromethaneHPLC, 1H NMR, 13C NMR[16]
46β-Sitosteryl glucoside 6′-O-aliphatatesStemsdichloromethaneHPLC, 1H NMR, 13C NMR[16]
47β-Sitosterol palmaitateStemschloroformHPLC, 1H NMR, 13C NMR[50]
48CampesterolStemspetroleum etherGC-MS[51]
49γ-SitosterolStemspetroleum etherGC-MS[51]
HR-MS: High-resolution mass spectrometry; HPLC: High-pressure liquid chromatography; TLC: Thin layer chromatography; 13C NMR: Carbon-13 nuclear magnetic resonance spectrometry; 1H NMR: Hydrogen-1 nuclear magnetic resonance spectrometry; GC-MS: Gas chromatography–mass spectrometry.
Table 5. Saccharides and glycosides isolated from Cynomorium songaricum Rupr.
Table 5. Saccharides and glycosides isolated from Cynomorium songaricum Rupr.
No.CompoundParts of PlantExtract SolventIdentificationReferences
50GlucoseStemschloroformTLC, GC-MS[9]
51Zingerone 4-O-β-D-glucopyranosideStemsdichloromethaneFAB-MS, 1H NMR, 13C NMR, HMQC, HMBC[10]
52n-Butyl-β-D-fructofuranosideStemsethyl acetate1H NMR, 13C NMR[55]
53n-Butyl-α-D-fructofuranosideStemsethyl acetate1H NMR, 13C NMR[11]
54n-Butyl-β-D-fructopyranosideStemsethyl acetate1H NMR, 13C NMR[56]
55PiceidStemsethyl acetate part1H NMR, 13C NMR[16]
56ConiferinStemsN-butanol part1H NMR, 13C NMR[16]
57IsoconiferinStemsN-butanol part1H NMR, 13C NMR[16]
58AdenosineStemsN-butanol partHPLC, 1H NMR, 13C NMR[16]
59(−)-Isolariciresinol 4-O-β-D-glucopyranosideStemsaqueousFAB-MS, CD, 1H NMR, 13C NMR[42]
60(7S,8R)-Dehydrodiconiferyl alcohol 9′-β-glucopyranosideStemsaqueousFAB-MS, HPLC, 1H NMR, 13C NMR, CD, 1H–1HCOSY[42]
61NicolosideStemsaqueous1H NMR, 13C NMR[42]
62Songaricumone AFresh stemsethyl acetate partHR-MS, 1H-NMR, 1H–1HCOSY, HMBC, UV, TLC, CD[4]
UV: Ultraviolet spectrophotometry; TLC: Thin layer chromatography; GC-MS: Gas chromatography–mass spectrometry; FAB-MS: Fast atom bombardment mass spectrometry; HMQC: Heteronuclear multiple quantum coherence; HMBC: Heteronuclear multiple bond connectivity; HPLC: High-pressure liquid chromatography; CD: Circular dichroism; 13C NMR: Carbon-13 nuclear magnetic resonance spectrometry; 1H NMR: Hydrogen-1 nuclear magnetic resonance spectrometry; 1H–1HCOSY: Homonuclear Correlation Spectroscopy.
Table 6. Organic acids and organic acid ester isolated from Cynomorium songaricum Rupr.
Table 6. Organic acids and organic acid ester isolated from Cynomorium songaricum Rupr.
No.CompoundParts of PlantExtract SolventIdentificationReferences
63Protocatechuic acidStemsethyl acetate part1H NMR, 13C NMR[13]
64Gallic acidStemsethyl acetate part1H NMR, 13C NMR[13]
65n-Butyric acidStemsethyl acetate part1H NMR, 13C NMR[13]
664-Methoxycinnamic acidStemsethyl acetate part1H NMR, 13C NMR[48]
67p-Hydroxybenzoic acidStemsethyl acetate part1H NMR, 13C NMR[42]
68Methyl protocatechuicateStemsethyl acetate part1H NMR, 13C NMR[42]
69p-Hydroxycinnamic acidStemsethyl acetate part1H NMR, 13C NMR[16]
703,4-Dihydroxy-benzoic acid ethyl esterStemsethyl acetate part1H NMR, 13C NMR[57]
714-Hydroxyphenethyl 2-(4-hydroxyphenyl) acetateStemsethyl acetate part1H NMR, 13C NMR, HMBC, HMQC[48]
72Stearic acid α-monoglycerideStemsethyl acetate partESI-MS, 1H NMR, 13C NMR[13]
73Succinic acidStemsaqueous partIR, 1H-NMR[43]
74Ferulic acidStems70% alcohol1H NMR, 13C NMR[58]
75Gentisic acidStemsaqueous1H NMR, 13C NMR[49]
76Palmitic acidStemsaqueousEI-MS, 1H NMR, 13C NMR[49]
773,4-Dihydroxyphenethyl acetateStemsaqueousEI-MS, 1H NMR, 13C NMR[49]
78Vanillic acidWhole grassaqueous part1H NMR, 13C NMR[44]
79CapilliplactoneWhole grassethyl acetate partIR, 1H NMR, 13C NMR, 1H–1HCOSY, HMQC[59]
HMQC: Heteronuclear multiple quantum coherence; HMBC: Heteronuclear multiple bond connectivity; ESI-MS: Electrospray ionization mass spectrometry; IR: Infrared spectroscopy; EI-MS: Electron impact mass spectrometry; 13C NMR: Carbon-13 nuclear magnetic resonance spectrometry; 1H NMR: Hydrogen-1 nuclear magnetic resonance spectrometry; 1H–1HCOSY: Homonuclear Correlation Spectroscopy.
Table 7. Phloroglucinol adducts isolated from Cynomorium songaricum Rupr.
Table 7. Phloroglucinol adducts isolated from Cynomorium songaricum Rupr.
No.CompoundParts of PlantExtract SolventIdentificationReferences
80Epicatechin-(4β-2)-phloroglucinolFresh stems70% acetoneHPLC-MS, HPLC[41]
81Epicatechin-3-O-gallate-(4β-2)-phloroglucinolFresh stems70% acetoneHPLC-MS, HPLC[41]
82Catechin-(4α-2)-phloroglucinolFresh stems70% acetoneHPLC-MS, HPLC[41]
83Cynomoriitannin-phloroglucinol AFresh stems70% acetoneCD, 1H NMR, 13C NMR[41]
84Cynomoriitannin-phloroglucinol BFresh stems70% acetoneCD, 1H NMR, 13C NMR[41]
85PhloroglucinolStemsaqueous1H NMR, 13C NMR[49]
HPLC-MS: High-performance liquid chromatography–mass spectrometry; HPLC: High-pressure liquid chromatography; CD: Circular dichroism; 13C NMR: Carbon-13 nuclear magnetic resonance spectrometry; 1H NMR: Hydrogen-1 nuclear magnetic resonance spectrometry.
Table 8. Other compounds isolated from Cynomorium songaricum Rupr.
Table 8. Other compounds isolated from Cynomorium songaricum Rupr.
No.CompoundParts of PlantExtract SolventIdentificationReferences
86MannitolStemsaqueous1H NMR, 13C NMR[49]
87ProtocatechualdehydeStems70% alcohol1H NMR, 13C NMR[58]
88ChrysophanolStems70% alcohol1H NMR, 13C NMR[58]
89EmodinStems70% alcohol1H NMR, 13C NMR[58]
90PhyscionStems70% alcohol1H NMR, 13C NMR[58]
91(−)-LariciresinolStemsethyl acetate part1H NMR, 13C NMR[57]
924-MethylcatecholStemsethyl acetate part1H NMR, 13C NMR[57]
934β-(L-cysteinyl)-catechinStems70% acetoneESI-MS, 1H NMR, 13C NMR[64]
944β-(L-cysteinyl)-epicatechinStems70% acetoneESI-MS, 1H NMR, 13C NMR[64]
954β-(L-cysteinyl)-epicatechin 3-O-gallateStems70% acetoneESI-MS, 1H NMR, 13C NMR[64]
964β-(L-acetylcysteinyl)-epicatechinStems95% alcoholESI-MS, 1H NMR, 13C NMR[64]
974β-(L-acetylcysteinyl)-epicatechin 3-O-gallateStems95% alcoholESI-MS, 1H NMR, 13C NMR[64]
984β-(L-acetylcysteinyl)-epiafzelechinStems95% alcoholESI-MS, 1H NMR, 13C NMR[64]
ESI-MS: Electrospray ionization mass spectrometry; 13C NMR: Carbon-13 nuclear magnetic resonance spectrometry; 1H NMR: Hydrogen-1 nuclear magnetic resonance spectrometry.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, J.; Chen, X.; Han, L.; Ma, B.; Tian, M.; Bai, C.; Zhang, Y. Research Progress in Traditional Applications, Phytochemistry, Pharmacology, and Safety Evaluation of Cynomorium songaricum. Molecules 2024, 29, 941. https://doi.org/10.3390/molecules29050941

AMA Style

Zhang J, Chen X, Han L, Ma B, Tian M, Bai C, Zhang Y. Research Progress in Traditional Applications, Phytochemistry, Pharmacology, and Safety Evaluation of Cynomorium songaricum. Molecules. 2024; 29(5):941. https://doi.org/10.3390/molecules29050941

Chicago/Turabian Style

Zhang, Jin, Xingyi Chen, Lu Han, Biao Ma, Mengting Tian, Changcai Bai, and Ye Zhang. 2024. "Research Progress in Traditional Applications, Phytochemistry, Pharmacology, and Safety Evaluation of Cynomorium songaricum" Molecules 29, no. 5: 941. https://doi.org/10.3390/molecules29050941

APA Style

Zhang, J., Chen, X., Han, L., Ma, B., Tian, M., Bai, C., & Zhang, Y. (2024). Research Progress in Traditional Applications, Phytochemistry, Pharmacology, and Safety Evaluation of Cynomorium songaricum. Molecules, 29(5), 941. https://doi.org/10.3390/molecules29050941

Article Metrics

Back to TopTop